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Outline 
This report summarizes the effects of a range of Pluronics on cellular responses 
in bacterial and mammalian cells through a review of published findings. Effects of 
Pluronics on drug delivery, efflux systems, growth, and nutrition are reported for 
eukaryotic cells. For microbial cells, their effects on adhesion, movement, biofilm 
formation, energy status and secondary metabolism are discussed. Guided by findings 
in the literature, a series of experiments were conducted exploring the responses of a 
beneficial environmental soil microbe, Pseudomonas putida strain KT2440, to selected 
Pluronics. These results are presented. The report has four sections: an Introduction 
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that covers published literature on eukaryotic and prokaryotic cells, the results of studies 
on Pseudomonas putida strain KT2440 and the overall conclusion and potential future 
studies. Thus, the material is presented in the following sections: 
1. General Introduction 
1.1. Structural features of Pluronics 
1.2. Pluronics and mammalian cells, an overview 
1. 2. 1 Effects of Pluronic unimers on efflux pumps in mammalian cells 
1. 2. 2 Responses of other Eukaryotes 
1.3. Pluronic effects on bacteria 
1.3. 1 Efflux pumps in bacterial cells 
1.3.2 Types of ATPase 
1.3.3 Synergy between Poloxamer and antibiotics in antimicrobial activity 
1.3.4 Pluronics and surface attachmentlbiofilm formation 
2. Examination of metabolic effects of Pluronics on an environmental bacterium, 
Pseudomonas putida KT2440 
2.1 Metabolic changes reported through bioluminescence 
2. 1. 1 Methods 
2. 1. 2 Results 
2.2 Cell culturability assessments 
3. Discussion 
4. Conclusions and future directions 
1. General Introduction 
1.1 Structural features of Pluronics 
5 
Pluronic block co-polymers consist of ethylene oxide (EO) and propylene oxide (PO) 
blocks arranged in a linear A-B-A structure: EOa-POb-EOa as is illustrated in Figure 1 
where a = number of hydrophilic EO units and b = number of hydrophobic PO units. The 
water solubility and properties of the copolymer vary with the changes in chain lengths 
(Figure 1 ). 
Figure 1: Pluronic molecular formula. 
Pluronics, a trademark of the BASF Corp that manufactures these chemicals, are 
designated with a letter to define their physical form at room temperature followed by 
two or three digits. Letter 'L' denotes liquid, 'P' denotes paste, and 'F' denotes flake or 
solid. In the numerical designation, the first digit (two digits in a three-digit number) 
multiplied by 300, gives the approximate mass of the PO hydrophobe; and the last digit 
multiplied by10 gives the percentage EO content (Figure 2). For the generic term 
"poloxamer", copolymers are designated with the letter "P" followed by three digits. The 
first two digits multiplied with 100 indicate the approximate molecular weight of the PO 
hydrophobe, and the last digit multiplied by 10 gives the percentage EO content. 

















Hydrophile (10 to 80% Polyoxyethylene) 
Figure 2: Compositions of EO and PO in Pluronics. The physical state of the Pluronics 
is indicated by the differently shaded regions in the Figure. 
Source: http://www2.basf.us/performancechemica1/bcperfpluronic_grid.html. Circles 
designate the Pluronics discussed in this report. 
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The Pluronics range in molecular weights (MW) from a few kD to over 14 kD 
(Figure 2, Table 1). The number of hydrophilic EO (a) units and lipophilic PO (b) units 
defines the hydrophilic-lipophilic balance (HLB) and critical micelle concentration (CMC) 
of individual polymer. Small variations in a and / or b may result in co-polymers with 
similar MWs but highly different physical properties. Depending on the Pluronic MW 
and a:b ratio the properties are tuned to specific applications such as wetting agents, 
emulsifiers, defoaming agents, and lubricants 
[http://wwwstage.basf.com/performancechemical/bcperfapplications.html]. 
Table 1 shows the physicochemical characteristics of several Pluronics. 
Table 1: Physiochemical properties of selected Pluronics (Kabanov et al., 2003) 
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HLB is an expression used to demonstrate the relationship between the 
hydrophilic and hydrophobic groups of a surfactant. The HLB dictates polymer 
amphiphilicity and the resulting surface activity. HLB values shown in Table 1 are 
obtained from data reported by BASF Corporation. There are many publications that 
discuss theoretical or experimental methods to determine HLB values. Griffin (1949) 
computed HLB = 20 * Mh/M; Mh = molecular mass of the hydrophilic EO region and M = 
molecular mass of the whole molecule. According to Davies' method (Davies, 1957), 
HLB can be calculated as: 
8 
HLB = 7 + L (hydrophilic group numbers)+ L (lipophilic group numbers) 
Though the Davies' method is easy, these calculated HLB values for polyethoxylated 
surfactants differ significantly with experimental data. Guo et al. (2006) addressed this 
limitation of Davies' method by the introduction of effective chain length for straight alkyl 
chain, EO chain, and PO chain in the calculation. 
Pluronics self assemble into micelles in aqueous solutions above a concentration 
called the critical micelle concentration (CMC). Below the CMC, Pluronics exist in 
solution as isolated molecules known as unimers. Kabanov et al. ( 1995) studied 
Pluronics F68, F108 and P85 in aqueous solutions to determine their CMC using 
surface tension measurements and fluorescent probes. Light scattering and 
ultracentrifugation techniques were utilized to determine the size and molecular masses 
of micelles. Figure 3 depicts the structure of a Pluronic micelle (average diameter 
ranges from 15 to 35 nm, Kabanov et al., 1995) or 10 to 100 nm (Batrakova and 
Kabanov, 2008) with hydrophilic EO chains facing outward and hydrophobic PPO 
chains forming the inner boundary surface. 
The hydrophobic inner core of micelles serves as a microenvironment for the 
incorporation of hydrophobic drugs while the hydrophilic outer shell maintains the 
dispersion stability of micelles (Oh et al., 2004). This characteristic of Pluronic micelles 
makes them an attractive candidate as a drug delivery vehicle. Micelle-drug delivery 
enhances the transport of low molecular substances across cell membranes (Slepnev et 
al., 1992) permitting easy penetration into capillaries of the target cells (Kabanov et al., 
1995). Such Pluronic micelles deliver drugs across the blood brain barrier (Kabanov et 
al., 2003), permit oral delivery (Batrakova et al., 1998) and allow tumor specific delivery 
of anti neoplastic agents (Kabanov et al., 2002). Also, these drug delivery-
microcontainers reduce the interaction of the drug with blood or other external cell 
components increasing their stability as they circulate in the blood system (Kabanov et 





Figure 3: Pluronic block copolymer in micelle form showing encapsulation of a drug 
(Batrakova et al., 2008). At a concentration above CMC, these copolymers self-
assemble into micelles capable of carrying hydrophobic molecules. 
1.2 Pluronics and mammalian cells, an overview 
Several studies focus on the interaction of Pluronics with mammalian cells 
(Kabanov et al., 1995, 2005; Batrakova et al., 2003; reviews: Batrakova and Kabanov, 
2008; Alakhova et al., 2009). As illustrated in Table 2 the findings have a direct 
relationship to biomedical and pharmaceutical fields. 
9 
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Table 2: Pluronics and mammalian cells 
f>luronics Type of cells Mode of action/time of efficacy References 
F108, L35, L121 Bovine brain Inhibition of Pgp efflux system in Batrakova 
and P85 micro BMECs at below CMG level of et al., 2003 
endothelial individual Pluronic; altered membrane 
cells fluidization; ATP level changes. 
(BBMEC) 
P85 Kidney At 0.01 wt% inhibits Pgp efflux pump; Batrakova 
epithelial cells inhibits ATPase activity and reduces et al., 2004 
ATP level. 
P85 Brain cells Micelles used as microcontainers for Kabanov et 
neuroleptic delivery into the brain. al., 1989 
P85 Human P85 ( ~.01 wt% concentrations) Alakhova et 
breast diffuses into mitochondria: inhibits al.,2009 
carcinoma respiratory chain complexes I and IV, 
cells depletes ATP. Reduces the function 
of drug efflux system. In MOR cells 
cause pre-apoptotic effects. 
L121 Human Stabilized Pluronic L 121 micelle (with Yang et al., 
epidermoid shell crosslinks) at 0.003 wt% inhibits 2007 
carcinoma efflux system in MOR cells and 
KBv cell line depletes ATP. 
The Pluronics influence drug performance in normal cell lines and more 
effectively in multidrug resistant (MOR) cells. Pluronics are considered as inert 
components that play a crucial role in protecting drugs from degradation. Pluronics also 
help in increasing drug exposure to tissues and their transport into cells. However, as 
demonstrated in Table 2, certain Pluronics do affect mammalian cell functions that 
contribute to drug efficacy. Altered responses include changes in membrane 
microviscosity, inhibition of the electron transport chain in mitochondria, reduced ATP 
level, impaired Pgp efflux systems, and altered respiration, (Batrakova et al., 2002; 
Kabanov et al., 2005; Alakhova et al., 2009). 
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Two modes of action must then be considered depending whether the Pluronics 
are present at concentrations above or below the CMC. As discussed already, above 
the CMC, Pluronic micelles physically encapsulate and transport drugs across cell 
membranes (Slepnev et al., 1992). They permit oral delivery (Batrakova et al., 1998) 
and will target drugs to the central nervous system (CNS) across the blood brain barrier 
(Kabanov et al., 2003). However Pluronics are also active below their CMC values as 
unimers leading to reduced ATP levels and altered drug efflux as is discussed in the 
next section (Batrakova et al. 2003, 2004 ). 
1.2.1 Effects of Pluronic unimers on efflux pump in mammalian cells 
Efflux pumps are major causes of anticancer drug resistance in eukaryotic cells 
(Batrakova et al., 2003; Fatma et al., 2006). Figure 4 illustrates a model for a 
mammalian cell Pgp efflux pump performing drug extrusion. If the pump is in the plasma 
membrane, then drug concentration is reduced in the cell interior through its function. 
Two efflux pumps that are ATP-driven are the Pgp transporter, found in normal cell 
lines, and a multidrug resistance - associated protein transporter (MRP) (Homolya et al., 
2003) found in tumor cells. These pumps may normally be involved in the transport of 
organic anions or movement of lipid components (Homolya et al., 2003). 
Normal function of ATP-
dependent Pgp efflux 
pumps in cancer cells. 
D ugs are transported 




Figure 4: An ATP-dependent Pgp efflux pump extrudes drugs and other exogenous 
compounds from the cytoplasm (Webber and Piddoc, 2003). 
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Batrakova et al. (2003) using bovine brain micro endothelial cell (BBMEC) 
monolayers in studies with a range of Pluronics designated by circles in Figure 5, show 
how the reactivity of these compounds with Pgp-type efflux systems differs with their 
composition. To explore the effects on the drug efflux pumps, Batrakova et al. (2003) 
examine how Pluronics influenced the intracellular level of a dye R123 that is a 
substrate for a Pgp transporter in the plasma membrane. Figure 6 shows how each of 
four Pluronics differentially affects accumulation. In Figure 6A arrows from left to right 
correspond to the CMC of Pluronics L 121, P85, F108, L35 used at a range of 
concentrations in the exposure of BBMEC cells for 60 min. Accumulation of R123 
reaches a maximum level below the CMC values for each Pluronic and decreases 
above the CMC value. This result is consistent with earlier studies (Batrakova et al., 
1998) demonstrating that Pluronic unimers (single molecular chains of the block 
copolymer) inhibit the Pgp efflux pump. A R123 enhancement factor (R123 levels in the 
13 
presence of Pluronic /R123 levels in the absence of Pluronic) was calculated and 
plotted versus the length of PO block for each copolymer (Figure 68). Figure 68 shows 
that P85 and L81 both with intermediate PO chain lengths are the best inhibitors 
although they differ in HL8 (16 and 2, respectively, Table 1 ). Another Pluronic with HL8 
similar to P85, L35 (HL8 19) has little activity nor do hydrophilic Pluronics F38 (HL8 31) 
and F127 (HL8 22, Table 1) that have short and long PO chain lengths, respectively. 
Similarly, activity is weak with Pluronic L 121 (HL8 1 ), which has long PO chains. There 
appears not to be a direct correlation between HLB and affects on R123 dye 
accumulation in 88MEC monolayers. 
T~ 
--•777 
-~--+-- F S 
Hydrophile (10 to 80 ~ polyoxyetllylene) 
Figure 5: Pluronic grid shows the Pluronic (with circles) that are used in the study of 
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Figure 6: (A) concentration effects of various Pluronics on R123 accumulation in 
BBMECs. (8) Relationship between the R123 accumulation enhancement factor and 
the length of lipophilic PO segment (Npo) in Pluronic block copolymers (Batrakova et 
al., 2003). Pluronics with HLB >20 are indicated by empty circles and Pluronics with 
HLB <20 are shown by filled circles. 
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In another earlier study, Batrakova et al. (2001) proposed that membrane 
fluidizers abolish Pgp ATPase activity thereby inactivating Pgp-mediated drug efflux. 
They report (Batrakova et al., 2001) that P85 inhibition of Pgp ATPase activity occurs in 
the same dose range that is inhibitory to Pgp efflux in BBMEC monolayers. Batrakova et 
al. (2003) correlate effects of Pluronics on R123 accumulation in the cytoplasm of these 
cells with changes in membrane microviscosity as shown in Figure 7. All Pluronics were 
added at concentrations (less than CMC level) producing maximal accumulation of 
15 
R123 in BBMECs (Figure 6). The hydrophilic Pluronic F88 (39 PO units, HLB 28, Table 
1) and Pluronic L35 with 16 PO units (HLB 19, Table 1) caused membrane solidification, 
as evidenced by an increase in the membrane microviscosity. In contrast, the most 
lipophilic Pluronic L 121 (68 PO units, HLB 1, Table 1) and a Pluronic with an 
intermediate lipophilicity P85 (40 PO units, HLB 16, Table 1) decrease the membrane 
viscosity. With P85 these effects occur with the unimers, i.e. at concentrations below the 
CMC. More recent studies show that P85 unimers enter cells through lipid raft docking 
and calveolae formation (Sahay et al., 2010) In contrast entry of P85 micelles of 14.5 
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Figure 7: Kinetic effects of various Pluronics on the total membrane microviscosity in 
BBMEC (Batrakova et al., 2003). 
The Pluronics also alter cellular ATP levels as shown in Figure 8. An ATP 
depletion factor (intracellular ATP in the absence of Pluronic /ATP levels in the 
presence of Pluronic) was calculated and plotted versus the length of PO block for each 
copolymer. In general, the hydrophilic Pluronics F38 (HLB 25), F88 (HLB 28), F108 
(HLB 27), and F127 (HLB 22) had negligible effect on ATP levels showing that for these 
Pluronics with high HLBs PO length was not a decisive factor of PO units. However 
there was a linear relationship with PO length for the series L35, L43, L64 and P85 
where activity increased with PO chain length. Conversely for P85, L 101 and L 121 




















0 20 40 60 80 
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Figure 8: Relationship between the ATP depletion factor and the length of PO 
segments (Npo) in Pluronic block copolymer (0.01 % w/v concentration) (Batrakova et 
al., 2003). Pluronics with HLB >20 are indicated by empty circles and Pluronics with 
HLB <20 are shown by filled circles. 
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Confocal microscopy results (Figure 9) using FITC-labeled Pluronics (F108, L35, 
P85 and L 121) at 0.01 % w/v on BBMEC for 2 hat 37 °C show differential internalization 
of copolymers into the cells. Hydrophilic Pluronic F108 (HLB 27) shows poor 
internalization into cells (Figure 9A). Pluronic L35 (HLB 19) with short PO block and 
more lipophilic Pluronic P85 with intermediate PO blocks (HLB 16) accumulate 
throughout the cells (Figure 98 and Figure 9C). The most hydrophobic Pluronic L 121 
(HLB 1) localizes within endocytic compartments. These compartments are part of the 
endocytic membrane transport pathway from the plasma membrane to the lysosome. 
During endocytosis materials are absorbed by engulfment. 
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Figure 9: Localization of FITC-labeled Pluronic F108 (A), P85 (8), L35 (C) and L 121 (D) 
using confocal microscopy (Batrakova et al., 2003). 
Based on these findings the group speculates on why the composition influences 
Pluronic effects. Lack of internalization of hydrophilic Pluronic F108 may be the cause of 
its inability to affect Pgp efflux and ATP level. The extremely lipophilic copolymer L 121 
is sequestered in endosomes and did not change ATP level dramatically nor affect Pgp 
efflux. Both L35 and P85 enter the cell, but L35 marginally affects ATP levels whereas 
P85 is the strongest inhibitor of those tested; these two Pluronics have opposite effects 
on membrane fluidity decreasing and increasing respectively and they have different PO 
chain lengths. 
Alakhova et al. (2009) continue the examination into the role of Pluronic P85. 
Earlier studies (Rapport et al., 2000) suggest that Pluronics may inhibit respiration in 
mitochondria. Alakhova et al. (2009) revisit this possibility in studies where they 
compared responses of MOR cells and nonresistant cells to P85. They discuss how 
changes in the function of MOR cells compared with normal cell lines enhance their 
sensitivity to the effects of P85. The distinct properties of the MOR cell lines include: 
1) Mitochondria expressing high levels of mitochondrial uncoupling protein 2 
(UCP2) resulting in inefficient ATP synthesis and low membrane potential 
(Harper et al., 2002). 
18 
2) The preferential use of fatty acids over glucose as a source of electrons entering 
the respiratory chain and the generation of more lactate due to fermentation. 













Figure 10: Western blot analysis of Pgp expression in 1) non-MOR 2) MOR cells 
(Alakhova et al., 2009). 
Figure 11 shows how ATP levels in both cell types are altered by Pluronic P85. The 
half maximal effective concentrations EC5o of P85 for MOR and non-MOR cells are quite 
different with the MOR cells being sensitive to much lower concentrations. In both types 
of cells, ATP levels initially increased and then sharply decreased in response to 
increasing concentrations of Pluronic. However, increases occurred in the MOR cells 
19 
only at doses below 0.001 % wt, whereas ATP increased in the normal cells from 0.001 
% to about the CMC value after which a rapid decline occurs. 
250 
200 





0.0001 0.001 0.01 0.1 
[Pluronic], %wt 
Figure 11: Effects of P85 on the intracellular ATP levels in drug-resistant (MOR) 
MCF?/AOR (empty diamonds) and drug sensitive MCF7 (filled diamonds) cells. ECATPso 
values corresponding to 50% decrease in ATP levels for each cell line are shown by 
arrows (Alakhova et al., 2009). 
Figure 12 shows oxygen consumption following exposure of MOR and non-MOR 
cells to P85. In both cells types, as the Pluronic concentration increases the oxygen 
consumption decreases suggesting inhibition of respiration. With the MOR cells, oxygen 
consumption decreases rapidly with P85 above 0.001 % wt. For the normal cell line, 
oxygen consumption increases to a threshold at 0.01 wt. % P85 after which it decreases 
with Pluronic concentration. This finding suggests that changes in ATP levels in 
response to Pluronic exposure are due to effects on respiration. 












0 50 - -·--·-··· ............................. . 
0 
0.001 0.01 0.1 
[Pluronic), % wt 
20 
Figure 12: Effects of P85 on oxygen consumption in MCF7/AOR (MOR, empty 
diamonds) and MCF7 (non-MOR, filled diamonds) cells. ECREs5o values corresponding 
to 50% decrease in oxygen consumption for each cell line are shown by arrows 
(Alakhova et al., 2009). 
To determine the components of respiration affected by Pluronic P85, Alakhova 
et al. (2009) further characterized the effect of P85 on mitochondrial oxidative 
phosphorylation in MOR and non-MOR cells. Again the dose response curves in 
preparations from the two cell types are distinct although for both the target sites are 
cytochrome c oxidase (complex IV) and NAOH-ubiquinone oxidoreductase (complex I) 
rather than other complexes in the chain (Figure 13). In MOR cells, a dose-dependent 
decrease is seen for complex 1 when P85 concentrations are increased above 0.0001 
% wt. With the normal cell lines, low doses (0.0001 to 0.001 wt. %) increase activity 
after which there is a decline. For complex IV the increasing concentrations of P85 
suppress activity in MOR cells, but with normal cells there initially is an increase up to a 
threshold of 0.01 wt% exposure before inhibition. Membrane potential also is sensitive 
to P85 with dose responses differing between normal and MOR cells (Figure 13C). 
Increases occur with both normal and MOR cells up to a threshold where the potential 
declines. Threshold points are lower for MOR (0.01 wt%) compared with 0.1 wt% for 
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Figure 13: Effects of P85 on the activities of (A) complex I, (B) complex IV and (C) 
membrane potential in isolated mitochondria of MCF7/AOR (MOR, empty diamonds) 
and MCF7 (non-MOR, filled diamonds) cells. EC5o values corresponding to 50% 
decrease in complex I and complex IV activities for each cell lines are shown by arrows 
(Alakhova et al., 2009). 
Pluronic-altered mitochondrial function in the MOR cells likely causes oxidative 
stress due to aberrant electron flow to oxygen. Enhanced production of ROS (Figure 14 
22 
A, Ott et al., 2007) and cytochrome c release (Figure 14 B) signify a pro-apoptotic 
condition is generated within the MOR cells. For MOR cells, the threshold level for ROS 
production is lower 0.01 wt% than that for cytochrome c release (0.1 %). The 
nonresistant normal cells do not show enhanced ROS or cytochrome c release. These 
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Figure 14: Effects of P85 on (A) ROS production and (B) cytochrome c release in 
MCF7 (filled diamonds) and MCF7/AOR (empty diamonds) cells (Alakhova et al., 2009). 
In summary, in mammalian cell lines, Pluronic P85 affects metabolism at 
concentrations below and above CMG values. The reprogramming of cells to become 
multi drug resistant increases sensitivity and results in Pluronic-induced changes that 
are apoptotic. Generally the MOR cells respond to lower concentrations of P85 than the 
normal cell line. Changes in both cell types are caused by intracellular penetration of 
23 
P85 into the mitochondria to alter electron flow and membrane potential due to inhibition 
at complex I, which releases electron and pumps protons across the membrane while 
oxidizing NADH, and complex IV, which reduces oxygen. Consequently, other observed 
changes are reduced oxygen consumption and reduced ATP levels. An important 
consequence in the MDR cells is reduced efficacy of drug efflux from the cell by the 
over expressed Pgp efflux pumps. Both the lower ATP levels and direct inhibition of the 
ATPase activity of these pumps induced by P85 contribute to the reduced drug efflux 
activity. In the conclusion, of value to the medical field is the selective 
chemosensitization of MDR cells caused by Pluronics. However, even in normal cell 
lines higher concentrations of P85 above the CMC levels (0.1 to 1 %) reduce 
mitochondrial function and ATP levels. 
1.2.2 Responses of other eukaryotes 
Other eukaryotic cells, in addition to mammalian cell lines, are affected by 
Pluronics. Pluronic F68 at 0.01 % protects Tetrahymena cells against chemical and 
physical stress (Larsen et al., 2000). A Tetrahymena is a 50 µm long, rod-shaped 
ciliated freshwater protozoan that is used as a model for varied biomedical research as 
illustrated in Figure 15. 
Figure 15: Tetrahymena cells stained with DAPI (diamidino-2-phenylindole) nuclear 
fluorescent stain (Credit: Jacek Gaertig, University of Georgia, Athens). 
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Pluronic F68 at 0.01 % below the CMC level enhances survival of Tetrahymena 
cells during starvation when cells are dispersed in HEPES buffer containing essential 
salts (Ca2+, Mg2+). Table 3 shows these data gathered over a range of temperatures. 
However, survival decreased when trace metals Zn+, Cu2+, Mn+, Fe3+, Co2+ (Eisen et al., 
2006) were used; trace metals are required at low levels but above a threshold level are 
toxic. The authors speculate that 0.01 % w/v F68 encapsulates these metal ions 
promoting their uptake to levels that become toxic (Table 3). Based on the work with 
mammalian cells, we speculate that another possibility is that the Pluronic eliminates 
the efflux pump systems that would reduce toxic metal levels. 
Table 3: Survival period (days) of Tetrahymena cells under nutrient starvation at 
different temperatures (Larsen et al., 2000). 
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Absence of Pluronic Presence of Pluronic (0.01 % w/v) 
Treatment 36°C 28°C 16°C 36°C 28°C 16°C 
None 4 8 21 17 28 35 
Salts 3 5 17 16 27 43 
rTrace Metals 0 2 3 1 2 4 
Other studies explored the effect of chemical and a physical stress imposed by 
growth on a rocker plate tilting up to 40° (Table 4). To measure the survival under just a 
chemical stress, filled tubes of cell suspensions were incubated horizontally. As 
compared to control cells, cells treated with 1 O mM Ca2+ and 1 O mM K+ show strongly 
reduced survival; 10 mM Na+ had less toxicity. Pluronic F68 at 0.01% protected cells 
exposed to Ca and Na, but not to K+. To provide a physical stress tubes were only half-
filled, and they were tilted. This combination promotes cell death but the addition of 
Pluronic result in 100% protection for Ca and Na exposure and prolonged survival for 
K+. The authors speculate that Pluronic F68 encapsulates these metal ions, thereby, 
reducing toxicity, and also stabilizing the cell membrane against physical stress. In 
mammalian cells Pluronics are thought to act as channels for K transport and this may 
account for the differential ion effects. Ramirez and Mutharasan (1990) suggest that the 
protective mechanism of F68 relies on its ability to decrease membrane fluidity through 
direct interaction with the plasma membrane; changes in membrane fluidity correlate 
with changes in shear sensitivity. 
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Table 4: Survival under stress with and without Pluronic F68. The numbers represent % 
tubes with surviving cells (% survival). The number in parenthesis indicates the number 
of tubes (Larsen et al., 2000). 
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Hydrophilic Pluronics (e.g. F68, F88, F108, etc., with 80% EO, HLB >27) protect 
other animal cell cultures against the physical stress of shear forces. For instance, 
Murhammer and Goochee (1990) find that 0.2% w/v Pluronic F68 protects Spodoptera 
frugiperda SF9 insect cells from detrimental effects associated with vortexing. At 
concentrations of 0.2 and 0.3%, F68, resistance towards shear stress in Spodoptera 
frugiperda SF9 cells increases 15 and 42 fold, respectively. 
Pluronic F68 at concentrations below the CMG level also protects post-thaw 
recovery of cryopreserved plant cells enhancing the biomass production and post-thaw 
viability (Lowe et al., 2001 ). Cells, cryopreserved under liquid nitrogen at -196 °C, 
experience many respiratory imbalances, including ROS production upon transfer to 
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normal temperature. Pluronic F68 alone or in combination with an artificial oxygen 
carrier enhances cell viability reducing ROS levels (Lowe et al., 2001 ). Additionally, 
Cancino et al. (2001) report that Pluronic F68 (0.5 % w/v) enhances shoot regeneration 
in a citrus rootstock increasing fresh weight by 60% through protecting cells from 
environmental stress conditions and promoting uptake of nutrients. 
In summary, observations in common for these studies with different types of 
eukaryotic cells and tissues are the protective effects of Pluronics; protection is 
correlated with changes in membrane properties affecting responses to physical stress 
and transportation of nutrients and potential toxic materials. 
1.3 Pluronic effects on bacteria 
1.3. 1 Efflux pumps in bacterial cells 
Like the mammalian cells discussed in Section 1.2, bacterial cells also utilize 
efflux pumps for the extrusion of toxic substances such as antibiotics and heavy metal 
ions outside the cell. Through these transporters, bacterial cells exhibit multidrug 
resistance to antibiotics causing severe problems in the medical field (Webber and 
Piddoc, 2003) but conversely the bacteria are useful for clean up of metal- pollution. 
The bacterial efflux pumps localize in the cytoplasmic membranes, and some 
require ATP as a source of energy whereas others are coupled with pumping of 
hydrogen, sodium or potassium ions from outside the cells. Thus, these systems 
extrude drugs in an energy dependent manner, either by hydrolysis of ATP or by using 
the proton motive force (Schweizer, 2003). Illustrations of the different designs of these 
transporters are shown in Figure 16. LmrA from Lactococcus lactis is the first ABC-
multidrug transporter identified in bacteria, and it shares high homology with the Pgp-
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efflux pumps of mammalian cells (Vigano et al., 2000). Three other pump types use the 
proton motive force generated across the cell membrane rather than ATP hydrolysis. 
NorA probably is the best characterized efflux system in the Gram-positive bacteria. For 
a Gram-positive cell, only transport across the cytoplasmic membrane is required. 
Similarly, the AcrD system of the Gram-negative E. coli constitutes a cytoplasmic 
membrane transporter involved in the efflux of aminoglycosides into the periplasmic 
space. Other systems in the Gram-negative cells, such as the Mex transporter system, 
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Figure 16: Schematic illustration of main types of bacterial efflux pumps shown in 
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Lactobacil/us 
/actis. Illustrated are NorA (member of the major facilitator superfamily, MFS), AcrD and 
MexAB-OprM, two members of the resistance-nodulation division (RND) family and 
LmrA, a member of ATP binding cassette (ABC) family (Schweizer, 2003). 
1.3.2 Types of ATPase 
Several integral membrane protein complexes interact with ATP. Dependent on 
structure they are termed F, V, A, P and E type ATPases. The F and V designated 
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structures synthesize ATP and have greater complexity of protein subunits lodged into 
the membrane. These pump protons or Na+ against the gradient across the membrane 
utilizing the energy to generate ATP. The other structures use the hydrolysis of ATP to 
transport structures such as metal ions (P-type ATPases for heavy metal efflux, Peter, 
2005). 
Proton motive force cannot be generated in certain conditions such as a leaky 
damaged membrane, presence of uncoupler, etc. In such conditions, ATP-driven proton 
pumping activity of ATP synthase is regulated by mechanisms that suppress activity if 
no proton motive force is present (Feniouk, ATP synthase website (updated 2010): 
http://www.atpsynthase.info/). Thus, the changes caused by P85 to the membrane 
potential (pmf) of the mitochondria are consistent with the altered ATP levels as 
observed in the studies of Alakhova et al. (2009). 
1.3.3 Synergy between Poloxamer and antibiotics in antimicrobial activity 
Copolymer Poloxamer CRL-1072, generated by another manufacturer, enhances 
the activity of antibiotics on Mycobacterium avium - M. intracellular complex (MAI) while 
embedded in human U937 monocytoid cells (Jagannath et al. 1999).The PO mass of 
the structure is 3500 Da and the EO mass 200 Da. Thus, CRL-1072 has similar chain 
lengths to Pluronic L 101. A higher purity of CRL-1072 over the Pluronics is obtained by 
subjecting the material to supercritical fluid fractionation to remove low molecular weight 
materials (Jagannath et al. 1999). CRL-1072 is hydrophobic (Figure 1 ). 
Members of the MAI complex are resistant to antibiotics by two main 
mechanisms: ( 1) the natural permeability barriers of their thick and layered cell walls 
and (2) mutations acquired due to sub-lethal exposure (Jagannath et al., 1999). A 
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minimal inhibitory concentration (MIC) of the copolymer CRL-1072 for MAI growing in 
U937 cells of 5.0 µg/ml is observed. However, in the presence of CRL-1072, the 
antibiotic clarithromycin becomes bactericidal at concentrations at which it is only 
bacteriostatic when used alone. Synergism with the antibiotic clarithromycin is observed 
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Figure 17: Effects of CRL-1072 and clarithromycin on growth of MAI in human 
macrophages. Multiple doses of clarithromycin were added to MAI infected U397 
monocytoid cells on day 0 alone (closed circles) or with CRL-1072 at concentrations of 
0.125 µg/ml (open circles) or 0.25 µg/ml (squares) (Jagannath et al., 1999). 
CRL-1072 at 0.1 µg/ml similarly enhances the killing of MAI within human cells by other 
antibiotics (isoniazid [INH], rifampin, amikacin, streptomycin, and clindamycin) as shown 
in Figure 18. Thus CRl-1072 acts synergistically with antibiotics that differ widely in their 
modes of action. For instance INH inhibits cell wall formation, whereas rifampin and 
streptomycin are protein-synthesis inhibitors. This finding suggests that the Pluronic 
enhances the accumulation of the antibiotic rather than influencing the target of the 
antibiotic. As such it may enhance control of resistant strains by: 1) killing better and 
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limiting the chances for mutation to resistance. 2) enhancing uptake of antibiotics in 















Figure 18: Effects of CRL-1072 with antimycobacterial drugs on growth of MAI in 
macrophages. Five antibiotics were added to MAI infected U397 monocytoid cells on 
day 0, each at a sub-MIC of 5 µg/ml with (black bars) or without (white bars) 0.1 µg per 
ml of CRL-1072 (Jagannath et al., 1999). 
1.3.4 Pluronics and surface attachmentlbiofilm formation 
Adherence of microorganisms to surfaces in an aqueous environment can initiate 
the formation of a biofilm. In the biofilms the cells are surrounded by a matrix of 
materials some of which are secreted by the microbes. Biofilms are very common in 
nature e. g. dental plaque. In industry, biofilms cause clogs and corrosion in the interior 
of pipes. In medical science, infectious bacterial biofilms are one of the most common 
complications associated with implanted medical devices. A serious issue is the fact 
that cells within a biofilm are much more resilient to the effects of antibiotics; ie the act 
of biofilm formation induces a resistant state although the same microbial cells in a 
planktonic state are sensitive. Thus, one strategy for combating biofilm infections 
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combines the use of antibacterial agents along with blocking of initially adhesion and the 
subsequent biofilm growth. Studies demonstrate that Pluronic prevents biofilm formation 
of bacteria on polymer surfaces (Portales et al., 1995; Housley et al., 2009). 
Studies showing altered adhesion of cells are provided in Table 5. 
Table 5: Effect of Pluronics on adhesion 
Pluronics Cells Efficacy!Time of action References 
Pluronic F127 P. aeruginosa Limits adhesion of Pa (92- 99%), S. Portales et 
(Pa) S. aureus aureus (50-70%) and S. al., 1994; 
Reynolds epidermidis (50-70%) to hydrophilic Portales et 
S. epidermidis contact lenses. al., 1995 
M187sp8 
Pluronic F68 Staphylococcus Reduces adhesion to silicon wafers Levy et al., 
20% epidermidis 2004 
concentration 
Range of 15 Staphylococcus Inhibits adhesion on polystyrene. Bridgett et 
Pluronics epidermidis L31 affected all strains equally; F68 al., 1992 
spec. L31 strains more effectively 
and F68 900, 901 and 
904 
Portales et al. (1994, 1995) report that Pluronic F127 significantly inhibits (92-
99%) adhesion of Gram-negative Pseudomonas aeruginosa to hydrophilic contact 
lenses whereas F127 was found to reduce adhesion by the Gram-positive isolates 
Staphylococcus aureus and Staphylococcus epidermidis by 50-70%. Similarly, Levy et 
al. (2004) find that the hydrophilic Pluronic F68 allows only 3 % adhesion of S. 
epidermidis to ventricular catheters ( constructed of plastic material such as a silicone 
elastomer) and polystyrene surfaces. F127 blocks Gram-negative Escherichia coli D21 
adhesion to glass surfaces (Razatos et al., 2000). Bridgett et al. (1992) reported that S. 
aureus and S. epidermidis adherence to polymethylmethacrylate (PMMA) surface was 
strongly inhibited (approximately 22% of control) by Pluronic F127. Furthermore, F127 
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increases the susceptibility to antibiotics (vancomycin, and gentamicin) of residual 
adherent staphylococci. They also observed that increasing concentrations of F127 
enhance the inhibition of staphylococcal adherence. The Pluronics may function by 
passivation of the surface that the bacteria attach to or they may passivate the bacterial 
surface. This process would involve the creation of hydration layer on the cell surface, 
which then hinders bacterial adherence. 
Biofilm formation by an environmental pseudomonad, Pseudomonas 
ch/ororaphis 06, is differentially affected by Pluronics in manners altered by nutrition 
(Housley et al., 2009). Four Pluronics (P123, P104, F108, 25R2) varying in molecular 
weight and HLB have differential effects on biofilm formation although each Pluronic 
increased surface motility (swarming) to a similar extent. Enhancement of swarming is 
consistent with similar surface activity of each of the Pluronics. F108 and 25R2 
significantly reduce biofilm formation in a defined minimal medium, while P104 and 
P123 show little effect. In a rich medium, only P104 limits biofilm formation. These 
nutrient effects suggest that the primary mechanism is not through surface passivation. 
Rather the plasticity of the mechanisms involved in biofilm formation caused by nutrition 
results in differential sensitivity to the Pluronics. The Pluronics also affect phenazine 
production in this bacterium, Pluronic 25R2 increases production, whereas P104 and 
P123 cause decreases and F108 has no effect (Housley et al., 2009). Because 
phenazine production is energy dependent, it seems that the effective Pluronics could 
influence the energy status of the cell. 
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2. Examination of metabolic effects of Pluronics on an environmental bacterium, 
Pseudomonas. putida KT2440 
2.1 Metabolic changes reported through bioluminescence 
The aim of this study was to examine the effects of different Pluronics on P. 
putida KT2440. Pluronics are being used widely as wetting agents, emulsifiers, 
defoaming agents, lubricants, cosmetics, and pharmaceuticals (Fusco et al., 2006). 
They have several roles in agriculture including being part of the formulations for 
pesticides. This varied use stems from their commercial availability over a wide range of 
molecular weights and hydrophilic: lipophilic ratios (HLB), chemistries that allow 
different properties. Thus, with the increasing use of Pluronics, it is important to 
understand how Pluronics might affect beneficial soil bacteria. 
Although Pluronics are thought of being "inert carrier compounds" some show the 
ability to alter discrete cellular functions as discussed in the literature review in Section 
1.2. For instance, a copolymer was bactericidal for a mycobacterium complex within 
human cells (Jagannath et al., 1999). This polymer also promotes killing of the 
mycobacterium complex by a range of antibiotics (Jagannath et al., 1999). 
Selected Pluronics differentially affect biofilm formation by a soil pseudomonad 
Pseudomonas chlororaphis 06 depending on nutrition (Housley et al., 2009). Thus, 
Pluronics may have an impact on a process essential for survival as a root colonizer. 
Altered production by Pluronics of antibiotics termed phenazines in this same 
pseudomonad also occurs; again a process that could affect survival of the bacterium in 
soils (Housley et al 2009). 
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Pluronic studies in animal cells reveal that some are highly damaging to the 
activity of the electron transport chain (Alakhova et al., 2009). At concentrations above 
the CMC value of P85, normal animal cell lines show inactivation of the electron 
transport chain (at complexes I and IV), reduction in oxygen consumption to 50% of the 
control value, decreases in ATP levels to 20% of control and reduction by 50% of the 
membrane potential of isolated mitochondria. 
The energy demand in aerobic bacterial cells also is met by electron transfer 
chains that exist in the plasma membrane and it has not been demonstrated whether 
the bacterial complex I and IV are sensitive. Consequently, we examined the effects of 
Pluronics on bacterial energy status using an engineered strain of Pseudomonas putida 
KT2440. This biosensor emits light based upon a luciferase enzyme expressed from a 
plasmid containing a fusion between the promoter of the gene at locus PP _0588 with 
the /uxAB genes (Gajjar et al., 2009). Transcription of the /uxAB cassette produces a 
message that is translated to the LuxA and LuxB subunits that constitute an active 
luciferase (Miller et al 1997). This luciferase requires FMNH2 production and an 
aldehyde substrate [RCHO], such as decanal. Light is emitted in the oxidation of the 
aldehyde (Eq. 1) (Koga et al., 2005). 
RCHO + FMNH2 +02 - RCOOH + FMN + H2O + hv. [1] 
In the cell NADH reduces flavin mononucleotide [FMN], thus, generating FMNH2 (Eq. 2). 
[2] 
Thus, luminescence is dependent on energy level of P. putida cells. Previously 
we have shown that this strain responded with loss in light output when exposed to toxic 
heavy metals and metal-containing nanoparticles (Galiar et al., 2009). With exposure to 
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Cu ions and Ag ions and NPs, there was a loss in light output that correlated with loss in 
cell culturability. Consequently in these studies In addition to examining changes in light 
output, we measured cell culturability after 60 min of exposure to the Pluronics to 
determine whether any changes in Lux activity correlated with toxicity. 
Strain KT2440 is a good model for a beneficial environmental isolate. This 
pseudomonad has bioremediation potential and is a strong root-colonizer (Molina et al., 
2006; Child et al., 2007; Ramos-Gonzalez et al., 2005). Root colonization may involve 
its ability to generate biofilm (Avevalo et al., 2005, Housley et al., 2009) and exhibit 
surface motility (Housley et al., 2009; Matilla et al., 1987; Mozes et al., 1987). 
We selected for our study Pluronic 85 that has documented effects on animal 
lines (see Alakhova et al., 2009), plus, others that provide a range of MW and HLB as 
shown in Table 6. 
Table 6: Physicochemical properties of Pluronics used in the bacterial biosensor study 
Pluronics HLB CMC %wt. Molecular 
Weight 
L121 1 0.0004 4400 
L101 1 0.0008 3800 
L81 2 0.0063 2750 
L61 3 0.0022 2000 
L31 5 0.0231 1100 
L92 6 0.0010 3650 
P123 8 0.0025 5750 
P104 13 0.0020 5900 
P84 14 0.0300 4200 
L64 15 0.1400 2900 
P85 16 0.0300 4600 
F108 27 0.0320 14600 
F88 28 0.2800 11400 
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2.1.1 Methods 
Preparation of the biosensor 
Construction of the biosensor and its storage was as reported in Gaijar et al. 
(2009). Briefly, the cells possess a stable plasmid that bears a promoter fusion with the 
/uxAB reporter cassette. The promoter of the gene at locus PP _0588 was ligated to the 
reporter cassette so that the biosensor is termed strain PP _0588. 
Preparation of co-polymer solutions 
The list of the block copolymers used in this study and their characteristics are 
presented in Table 6 and Figure 1. Pluronics were kindly provided by BASF 
Corporation, NJ, USA. Aqueous solutions of Pluronic were prepared by using five g of 
Pluronic in 95 ml sterilized deionized water. The highly lipophilic Pluronics (L 121, L 101) 
gave cloudy solutions at RT. The 5% Pluronic solutions (50 ml) were sterilized in an 
autoclave at 121 °C for 30 min followed by stirring overnight. The prepared stock 
solution of Pluronic was made fresh weekly to limit the problems with possible microbial 
contamination. For these studies, all Pluronics were used within six months of receipt 
from BASF. 
Bioluminescence assay 
Logarithmic phase cells of the biosensor were generated by reculturing from an 
overnight culture grown in minimal medium (MM) with shaking at 25 °C to OD600nm=0.1. 
MM was prepared as described in Gaijar et al., (2009). MM contained in 1 L: 10.5 g 
K2HPO4, 4.5 g KH2PO4, 0.5 g sodium citrate (2H2O), 1.0 g (NH4)2 SO4, 0.25 g 
MgSO4.7H2O, and 2.0 g sucrose. The culture (200 ml) was centrifuged at 10,000 g for 
10 min and the pelleted cells were resuspended in 200 ml sterile distilled water and 
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used immediately in the Lux assay. The sterile distilled water was equilibrated to 25 °C 
to limit changes in light output due to temperature effects. After dividing into 50 ml 
aliquots in 125 ml flasks, the suspensions were amended with the 5% stock solution of 
Pluronic to generate final concentrations of 0.1, 0.25, 0.5, 0.75 and 1 % v/v of Pluronic. 
For the controls cells were suspended in water. Flasks were shaken at 200 rpm and 25 
C during the study. At defined times, 200 µI of the suspensions were transferred in 
triplicate into well plates for Lux readings. The luciferase substrate, 1 % decanal in 
ethanol, 10 µI, was added automatically in the LMAXII Luminometer (Molecular Devices 
Corporation, Sunnyvale CA). Light output was recorded with a 10 sec. exposure. The 
first data point was collected within 1 min of mixing Pluronic and bacterial cell 
suspension. Samples were withdrawn from the cultures every 10 minutes up to 1 h for 
the Lux assay. Each treatment had three analytical replicates within a study. The whole 
experiment was replicated in three or more separate studies. In the Results section, 
data for the effects of Pluronic on Lux activity are provided for one study typical of those 
performed. Results of other repeated studies are shown in an Appendix. The 
observation that the Lux activity for the control cells at time zero means that there would 
be large error bars negating any trend that is observed. The% RLU at defined 
concentration of Pluronic relative to control was calculated as: 
RLU at defined concentration 
X 100 
RLU of control 
In all of these studies there was no equilibration of the Pluronic into more dilute 
suspension before the assays were performed. 
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2.1.2 Results 
Group 1: Pluronics with strong inhibitory effect on Lux activity 
Four of the Pluronics gave strong rapid inhibition of Lux activity. These Pluronics 
termed Group 1 included highly hydrophobic Pluronics of similar MW, L 121 (HLB 1, 
CMC 0.0004, MW 4400), L 101 (HLB 1, CMC 0.0008, MW 3800), P123 (HLB 8, CMC 
0.0025, MW 5750) and P84 (HLB 14, CMC 0.0300, MW 4200). These Pluronics 
strongly inhibited Lux activity in a dose-dependent manner (Figures 19 and 20). Figure 
19 shows the rapid change in Lux output with time at different concentrations of the 
Pluronics. Inhibition in treated cells compared to control at 60 min was 98.3% for L 121; 
87.9% for P123; 69.2% for L 101 and 67.8% for P84. Figure 20 shows the% RLU 
relative to control for defined concentrations for Group 1 Pluronics at each 10 min 
interval of Lux assay. 
It is clear from Figure 20 that the Group 1 Pluronics show rapid, within a minute, 
dose-dependent inhibition in Lux response. Throughout the 60 min assay, Pluronic L 121 
(HLB 1) showed the highest inhibitory effect. With L 101, although it has the same HLB 
as L 121, the response curve differed with inhibition being maximum at 0.25 % dose. 
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Treatments Log IO %RLUat 
L121 Cfulml 60min 
Control 9.4±0.0 100.0±0.9 
0.1% 112±1.0 19.6±1.0 
0.25% 11.8±02 9.4:t0.2 
0.5% 11.5±1.7 3.2±0.1 
0.75% 11.8±1.6 22:tO.O 
T1me{m1n1 
1.00/4 9.9±0.6 1.7±0.0 
100 Treatments LoglO %RLUat 
LlOl CfuJml 60min 
Control 9.6±0.0 100.0±0.0 
0.1% 10.8±0.8 36.0±0.2 
0.25% 11.1±0.6 32.3±0.5 
0.5% 12.5±0.5 42.H0.4 
0.75% 11.6±1.6 48.3±1.0 
T,m~(mm) 1.00/o 12.6±02 30.8±0.5 
Treatments LoglO %RLUat 
P123 P123 Cfulml 60min 
Control 9.0±0.6 100.0±0.9 
0.1% 10.9±2.5 50.9±0.6 
3 
025% 10.9±1.3 27.2±0.3 
0.5% 11.3±2.2 18.8ffi.4 
0.75% 11.5±2.3 15.6±0.5 
C 11t1efm1r,) 1.0% 11.3±0.9 12.1±0.3 
Treatments Log IO %RLUat 
P84 Cfulml 60min 
Con1rol 9.3±0.5 100.0±0.9 
0.1% 10.6i0.l 63.8±1.0 
0.25% 11.3±0.5 51.2±1.1 
0.5% 12.3±1.6 41.3ffi.6 
0.75% 13.3±0.3 32.7±0.1 
1.0% 13.0±0.6 32.2±02 
Figure 19: Lux response of P. putida KT2440 biosensor exposed to Pluronics L 121 [A], 
L 101 [B], P123 [C] and P84 [D] at defined doses (mg/L). Changes in Lux output relative 
to control and cell culturability after 60 min of treatment are shown. Data are from one 
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study typical of at least three replicates generated under the same conditions. Means of 
analytical results and standard errors are shown. 
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Figure 20: % RLU relative to control for defined concentrations of Pluronics L 121, L 101, 
P123 and P84 Pluronics at 10 min intervals. Means of analytical results and standard 
errors are shown. 
Group 2: P/uronics with slight inhibitory effect on Lux activity 
Pluronics L92, P104 and F88 all reduced Lux output compared with the control 
cells but to a lesser extent, only about 40 % (Figure 21 and 22), than Group 1 (greater 
than 60 %) (Figures 19 and 20). Thus, they are termed Group 2 Pluronics. These 
Pluronics were L92 (HLB 6, CMC 0.0010, MW 3650), P104 (HLB 13, CMC 0.0020, MW 
5900) and F88 (HLB 28, CMC 0.280, MW 11400). Inhibition was observed rapidly with 
Pluronic L92 and P104. Dose-dependent inhibition was observed more slowly with 
Pluronic F88 requiring at least 10 min of exposure and concentration above its CMC 
value. Inhibition at 60 min in treated cells compared to the control was 42.9% with P104, 
38.6% with F88, and 21.4% with L92. Figure 22 shows % RLU relative to control at 
defined concentrations for Group 2 Pluronics at each 10 min time interval. With an 
increase in assay time, F88 had lesser dose-dependent inhibitory effect compared to 
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Figure 21: Lux response of P. putida KT2440 biosensor to L92 [A], P104 [B] and F88 
[C] Pluronics at defined doses (mg/L). Changes in Lux output relative to control and cell 
culturability after 60 min of treatment are shown. Data are from one study typical of at 
least three replicates generated under the same conditions. Means of analytical results 
and standard errors are shown. 
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Figure 22: % RLU relative to control for defined concentrations of Pluronics L92, P104 
and F88 Pluronics at 10 min intervals. Means of analytical results and standard errors 
are shown. 
Group 3: Pluronics that increased Lux activity 
A third group of Pluronics activated Lux output from the cells (Figures 23 and 24 ). 
These included L81 (HLB 2, CMC 0.0063, MW 2750), L64 (HLB 15, CMC 0.1400, MW 
2900) and P85 (HLB 16, CMC 0.0300, MW 4600). Lux responses to L81 and L64 
involved an initial decrease in light output, more for L64 than L81, followed by a shift 
with time to activation. Activation occurred more rapidly with L64 than L81. With P85, 
peak activation, about two-fold, occurred between 20 and 30 min for treatments at 0.25 
















































































Figure 23: Lux response of P. putida KT2440 biosensor to L81 [A], L64 [B], and P85 [C] 
Pluronics at defined doses (mg/L). Changes in Lux output relative to control and cell 
culturability after 60 min of treatment are shown. Data are from one study typical of at 
least three replicates generated under the same conditions. Means of analytical results 
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Figure 24: % RLU relative to control for defined concentrations of Pluronics L81, L64 
and P85 Pluronics at 1 0 min intervals. Means of analytical results and standard errors 
are shown. 
Group 4: Pluronics that produced variable responses between activation and 
inhibition of Lux activity 
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Figures 25, 26 and 27 show the Lux responses of Pluronics F108 (HL8 27, CMC 
0.0320, MW 14600), L61 (HL8 3, CMC 0.0022, MW 2000) and L31 (HL8 5, CMC 
0.0231, MW 1100), respectively. Variation in Lux response was observed between 
replicated assays with these Pluronics ranging from activation or inhibition and strong or 
weak responses. For F108 one assay showed very little change in Lux activity whereas, 
the second assay showed dose dependent activation (Figures 25A and 258). Changes 
in light output as a percent of the controls are shown in Figure 28. Activation to different 
levels occurred in replicate studies with L61 (Figure 26A and 268 and 29). This dose-
dependent increase in Lux response was more pronounced with assay time. With L31 a 
very rapid increase in light output was observed in one assay but there was inhibition in 
a second (Figure 27 A and 278 and 30). The two sets of assays for the designated 
Pluronic were performed with only a one day interval. In each of the assays the 
Pluronics were added from the 5% stock solutions to the water used for cell 
suspensions only just prior to addition of the cells. 
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Figure 25: Lux response (A) slight effect (8) activation of P. putida KT2440 biosensor to 
F108 Pluronic at defined doses (mg/L). Changes in Lux output relative to control and 
cell culturability after 60 min of treatment are shown. Means of analytical results and 





























































Figure 26: Lux response (A) slight activation (B) high activation of P. putida KT2440 
biosensor to L61 Pluronic at defined doses (mg/L). Changes in Lux output relative to 
control and cell culturability after 60 min of treatment are shown. Means of analytical 
results and standard errors are shown. 
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Figure 27: Lux response (A) inhibition (8) activation of P. putida KT2440 biosensor to 
L31 Pluronic at defined doses (mg/L). Changes in Lux output relative to control and cell 
culturability after 60 min of treatment are shown. Means of analytical results and 
standard errors are shown . 
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Figure 28: % RLU relative to control for defined concentrations of F108 Pluronic at 10 















-+-L61 activation -+-l61 activation 20 
20 
+l61 slight effect +L61 slight effect 
0 0 
0 0.1 0.25 0.5 0.75 0 0.1 o.z~· 0.5 0.75 







% RLU 100 %RLU 
80 100 
60 
40 50 -+-L61 activation 
-+-L61 activation 
20 +l61 slight effect + l61 slight effect 0 0 
0 0.1 0.25 0.5 0.75 0 0.1 0.25 0.5 0.75 





% RLU %RLU 
100 100 
so -+-L61 activation 50 -+-l61 activation 
+L61 slight effect +L61 slight effect 
0 0 
0 0.1 0.25 0.5 0.75 0 0.l 0.25 0.5 0 75 









+L61 slight effect 
0 
0 0.1 0 25 0.5 0.75 
% Concentration 
Figure 29: % RLU relative to control for defined concentrations of L61 Pluronic at 10 
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Figure 30: % RLU relative to control for defined concentrations of L31 Pluronic at 10 
min intervals. Means of analytical results and standard errors are shown. 
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2.2 Culturability assessments 
2.2.1 Methods 
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Cells, after a 60 minute treatment with or without Pluronic exposure, were 
assayed for culturability by dilution plating on salt-free 2% Luria Broth agar medium to 
determine whether changes in light output correlated with changes in culturability. This 
medium contained in 1 L: 1 0g Bactotryptone, and 5g Yeast extract (Difeo, Sparks, MD). 
Colonies were counted after 24 h incubation at 28 °C and the colony forming units 
(cfu)/ml determined. 
2.2.2. Results 
One way analysis of variance (ANOVA) was performed to determine the 
statistical significance of difference between (cfu)/ml values of various Pluronics. Table 
7 demonstrates the overall cell culturability per group of Pluronics. Statistical analysis 
(ANOVA) showed P value = 0.38 for the data set. Consequently, the Pluronic 
treatments had no significant effect on cell culturability. 
Table 7: Physiochemical properties and cell culturability for the Pluronics according to 
their Group activity with the biosensor 
Group of Pluronics HLB Average Average CMC% Molecular Cell culturability 
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Pluronics EO PO units wt. Weight (Log10 cfu/ml) of 1 % 
units of Pluronic 
concentration level 
Group 1: L121 1 10.00 68.28 0.0004 4400 9.9 ± 0.6 
Strong 
inhibitors 
L101 1 8.64 58.97 0.0008 3800 12.6 ± 0.2 
P123 8 39.20 69.40 0.0025 5750 11.3 ± 0.9 
P84 14 38.18 43.45 0.0300 4200 13.0 ± 0.6 
Group 2: L92 6 16.59 50.34 0.0010 3650 12.5 ± 0.6 
Slight 
inhibitors 
P104 13 53.64 61.03 0.0020 5900 12.3 ± 1.3 
F88 28 207.27 39.31 0.2800 11400 11.8 ± 1.0 
Group 3: L81 2 6.25 42.67 0.0063 2750 13.3±0.1 
Activators 
L64 15 26.36 30.00 0.1400 2900 11.2 ± 2.1 
P85 16 52.27 39.66 0.0300 4600 12.0±1.9 
Group 4: F108 27 265.45 50.34 0.0320 14600 11.3 ± 0.1 
Activators / 
inhibitors 
L61 3 4.55 31.03 0.0022 2000 11.9±0.1 
L31 5 4.00 17.00 0.0231 1100 11.0 ± 0.1 
3. Discussion 
The findings provided in this report illustrate that the energy status of an 
environmental pseudomonad was differently affected depending on the Pluronic used in 
the treatment. These studies add a new dimension to other Pluronic studies performed 
mainly with pathogenic bacteria (Portoles et al., 1994, 1995) where effects on biofilm 
production were correlated with surface passivation rather than changes in microbial 
cell metabolism. The altered metabolism that are reported here supports the work of 
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Housley et al (2009) where changes in production of secondary components, 
phenazines, clearly due to altered metabolism, were observed with Pluronic treatments 
of another environmental pseudomonad. Thus, both surface events and metabolism in 
microbes are sensitive to Pluronics. 
We correlate reduction in Lux output caused by some Pluronics with altered 
energy status because cellular generation of FMNH2 is required as a substrate for the 
luciferase enzyme in the biosensor. FMNH2 is generated using the reducing power of 
NADH produced through cellular metabolism. However, we do not know the mechanism 
by which the Pluronics affect their metabolic changes on Lux activity. Analogy with 
effects on mammalian cells would suggest that the functioning of the electron transfer 
chain is disturbed. Studies with both the normal and the MOR mammalian cell lines 
suggest a sequence of events occurs after exposure to Pluronic 85: 
1) Penetration through membranes with some effect on membrane 
microviscosity (Batrakova et al., 2003). 
2) Entrance into mitochondria to alter electron transport chain function at 
complex 1 and IV and levels of ATP 
3) Inhibition of the ATPase activity of efflux pumps that function to remove 
intracellular drugs. 
The mammalian cell response to P85 is highly sensitive to the concentration of 
the surfactant. This sensitivity is illustrated by the following findings for normal cell lines 
as reported by Alakhova et al. (2009): 
1) ATP levels increased below CMC but above CMC decreased to 20% control 
level. 
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2) Oxygen consumption above CMC dropped to 50% control level. 
3) In the Electron Transport Chain, Complex 1 activity was activated below 
CMC but inhibited above and complex IV increased in activity below CMC with little 
affect above CMC. 
4) Pluronic in the range 0.1 to 1 %, above the CMC, caused a 
50 % decrease in membrane potential value compared with control. 
The assays performed with the pseudomonad biosensor were in the range of 0.1 to 
1 %), and most were above the CMC value. Exceptions were for F88 (CMC 0.28% and 
L64 (0.13 %). It is interesting that for F88 there was no response in the bacterial cell 
light output at the 0.1 % dose. At 0.25% (around the CMC value) and higher inhibition 
was observed. In all other cases presumably the Pluronics interacted predominantly as 
micelles rather than unimers. The pseudomonad cell has complexes I to IV and an ATP 
synthase associated with oxidative phosphorylation in its plasma membrane. 
Consequently, we suggest that Pluronics could be changing the function of the electron 
transport chain. Elevated Lux output seen with Group 3 Pluronics, with dose relationship 
effects, could relate to better coupling of oxidative metabolism. However another 
possibility could be that there were impurities and degradation products that were active 
in these Pluronics. Decreased light output caused by exposure to Group 1 and Group 2 
could relate to impaired electron flow, loss of membrane potential and depletion of ATP. 
Group 4 Pluronics showed variable Lux responses between replicated assays in the 
extent of inhibition. Our interpretation is the interaction of these Pluronics with the 
bacterial cells is sensitive to the experimental conditions. All of the experiments were 
conducted in water; thus, any degradation products affecting solution pH would have 
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greater effects than in buffered solutions. The experiments were performed with 
Pluronics preparations obtained from December 2008 to May 2009 from the 
manufacturer. The manufacturer suggested shelf life of the products to be between 1 
and 2 years and they indicated that acids are generated upon aging. As of January 
2010 several of the Pluronic stocks at 5 % were highly acidic (Table 8). These findings 
question whether acidity or breakdown products generated the responses. Additionally 
the experiments were performed without an equilibration time for the dilution of the 
Pluronics into the cell suspensions. 
Table 8: pH of 5% Pluronic solutions as of Jan 2010 (Data courtesy of Alyssa Calder, 
2010) 
Date Received From Manufacturer Pluronics pH 
December'08 L121 5.28 
January'09 L101 3.47 
January'09 P123 4.65 
December'08 P84 6.22 
January'09 L92 3.66 
December'08 P104 6.51 
December'08 F88 5.99 
January'09 L81 3.68 
November'08 L64 3.80 
January'09 P85 6.10 
January'09 F108 NA 
January'09 L31 3.66 
January'09 L61 3.88 
'NA' denotes not available 
Batrakova et al. (2003) and Batrakova et al. (2008) found with mammalian cells 
that the molecular structure and composition of Pluronic copolymers influenced their 
activity. Some of the variance may be due to hindered penetration into the cell. Although 
P85 and L35 both penetrated mammalian cells, intracellular accumulation of L 121 was 
not observed and F108 appeared to remain on the cell surface. However, bacterial cell 
walls are quite different from membrane layer of mammalian cells with its plasticity. For 
61 
the Gram-negative pseudomonad there are two membrane layers. The inner layer, the 
plasma membrane, has a normal lipid bilayer, but the outer membrane has an outer 
leaflet containing the charged lipopolysaccharides. Additionally, the periplasmic space 
in between the two membranes has a band of extensively cross-linked polysaccharides 
termed the peptidoglycan layer. We do not know how these barriers to entry affect 
permeation of Pluronics into the cell or affect their surface interactions. Micelles of the 
predicted size of Pluronics, with average diameter ranges of 15 to 35 nm, (Kabanov et 
al., 1995), are larger than the predicted channel sizes or pores within the membrane 
that have a maximum diameter of less than 6 nm. Work with polyol penetration into a 
Gram-positive cell (thicker peptidoglycan layer but only the single plasma membrane) 
has a threshold cutoff of 1,200 (1.1 nm). Studies with P. aeruginosa suggested a 
smaller cutoff of 670 when oligosaccharides were used (Caulcott et al., 2006). 
Consequently it seems only L31 may be at the limit of permeability into the cell. Thus, 
we assume that the Pluronics exert their effects by surface interactions that disrupt 
normal membrane functions. 
Table 7 lists the physiochemical properties for the Pluronics according to their 
Group activity with the biosensor. It is perplexing that examination does not show a 
clear correlation between activity type and physiochemical property. Within each Group, 
there are Pluronics with low HLBs and relatively higher CMG values. Neither does the 
estimated chain length of the Pluronics show a correlative role. 
Hydrophile (10 to 80% Polyoxyethylene) 
Figure 31: Pluronic grid shows the Pluronic (with circles) that are used in our study. 
Although with some Pluronics there was a major decrease in light output, the 
cells retained normal culturability. Consequently although toxicity was displayed when 
sensing light output this did not lead to bacterial cell death. The concentration of 
Pluronic would be decreased by the serial dilution process used in the assessment of 
culturability performed after 60 min of contact. Reversibility of the effect of Pluronic 85 
also was demonstrated by Alakhova et al. (2009). Washing the animal cells to remove 
Pluronic P85 caused restoration of ATP levels, of Pgp activity and drug resistance in 
MOR cells. Although the drug efflux pump activity was restored in about 1 h, the ATP 
levels remained low for at least 5 h. Thus, it appears that both the bacterial cells and 
mammalian cells recover from inhibitory doses of Pluronics. It is interesting that 
previous studies (Gajjar et al., 2009) also found that loss in Lux output was not always 
correlated with bacterial cell death when cells were exposed to NPs of CuO and ZnO. 
The active player in these responses again is uncertain because the NP suspensions 
contain ions, NPs of 1-5 nm size and agglomerates of greater than 300 nm (Gajjar et 
al., 2009). It seems possible that membrane disturbances were occurring again to 
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reversibly affect electron transport. Thus, our studies do not clearly reveal a correlation 
between physiochemical properties of the Pluronics with their effects on biosensor 
luciferase output in the environmental pseudomonad. 
4. Conclusion and future direction 
Collectively these findings suggest that the molecular structure, composition and 
properties of the Pluronic molecule dictate the nature of its impact on beneficial soil 
microbes. However, we cannot pinpoint a clear feature from the HLB, CMG values or 
the EO or PO chain lengths to predict their activity. 
Pluronics have attracted global attraction during the last two decades for their 
use in medical science, consumer, industrial, and agricultural products. Thus with the 
increasing use of Pluronics, it is increasingly important to understand how Pluronics 
affect the environment. Our findings demonstrate that environmental soil microbes, such 
as P. putida KT2440, which has bioremediation potential, and the biological control 
agent P ch/ororaphis 06 (Gajjar et al., 2009) show changes in metabolism when 
contacted with certain Pluronics. Such changes could render them more susceptible to 
antibiotic or ROS damage and thus disrupt elemental cycles in the environment. 
Additional understanding of the role of Pluronics could come from the following 
studies: 
1) The Pluronics concentrations used in this study were above the CMCs 
suggesting that all effects were due to micelles. Studies should be run 
at lower levels to probe the role of Pluronics as unimers. Buffered 
solutions should be considered for the bioluminescence assays to 
address acidity associated with Pluronic solutions. 
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2) To probe the role of the outer membrane in Pluronic interactions studies 
could be performed with Gram-positive cells. 
3) To see whether, as in animal cells, Pluronic micelles can act as vectors, 
studies should be run in the presence of potentially toxic materials. 
Antibiotics, heavy metals and nanoparticles are appropriate 
amendments. 
Such studies may help better predict the potential environmental impacts of 
Pluronics on bacteria that have a role in soil processes. 
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Overview 
This appendix summarizes the data from all the repeated experiments including 
the data shown in results section 2.1.2. In the present study, effects of various Pluronics 
on P. putida KT2440 were observed using bioluminescence and cell culturability assay. 
We discussed earlier that the molecular structure and composition of Pluronic 
copolymers influenced their activity. Pluronics L 121, L 101, P123 and P84 showed 
strong inhibition in Lux response while Pluronics L81, L64 and P85 showed activation in 
Lux response. Pluronics L92, P104 and F88 showed slight inhibition in Lux activity. The 
same trend in Lux response in presence of Pluronics was observed for all the repeated 
studies. However, variations in RLU values were observed. This can be explained by 
any variation in day to day experimental conditions such as assay or room temperature, 
optical density of cells, age and pH of Pluronic solutions. 
Methods 
As described earlier in section 2.1.1. 
Results 
For each Pluronic, data from the repeated experiments are presented in the following 
manner: 
• RLU vs. Time graphs at different concentrations of Pluronic 
• RLU values with average and standard deviation from analytical triplicates of 
individual study in Tabular format 
• % RLU relative to control vs. concentrations graphs at every 10 min intervals of 
60 min Lux assay 
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Pluronic L 121: RLU vs. Time graph 
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Figure A 1: Lux response of P. putida KT2440 biosensor to L 121 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 12-18-2008, (8) Study 2 
performed on 1-13-2009, (C) Study 3 performed on 1-15-2009. Means of analytical 
replicates and standard errors are shown for each study. All the three studies with 
Pluronic L 121 were performed within 2 months of its receiving from the supplier. 
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Table A1: Lux response (RLU values) of P. putida KT2440 biosensor to L 121 Pluronic at 
:lefined doses (mg/L). RLU values from the replicate studies are shown in tables L 121 (A), (B) 
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Figure A2: % RLU relative to control for defined concentrations of Pluronic L 121 at 10 




Pluronic L 101: RLU vs. Time graph 
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Figure A3: Lux response of P. putida KT2440 biosensor to L 101 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 1-9-2009, (B) Study 2 
performed on 1-8-2009, (C) Study 3 performed on 1-10-2009. Means of analytical 
replicates and standard errors are shown for each study. All the three studies with 








Table A2: Lux response (RLU values) of P. putida KT2440 biosensor to L 101 Pluronic at 
defined doses (mg/L}. RLU values from the replicate studies are shown in tables L 101 (A), (B) 
and (C), respectively 
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60 34.6 36.7 37.3 35.2 1.411-. 1 1'0 .. 1-. 1 I 1-.., n1 12.3 128 12.3 125 n-, 1n ~ 1'1D 1nA 1n • 107 11 4 11 7 11 11.4 ti.::> 1A 17 1A 1 ... " 05 
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Figure A4: % RLU relative to control for defined concentrations of Pluronics L 101 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 























































































Figure AS: Lux response of P. putida KT2440 biosensor to P123 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 1-13-2009, (8) Study 2 
performed on 10-8-2008, (C) Study 3 performed on 10-10-2008, (D) Study 4 performed on 7-16-
2008. Means of analytical replicates and standard errors are shown for each study. Study 1 
94 
with Pluronic P123 was performed within a month of its receiving from supplier. However, age of 
Pluronic P123 was at least 6 months when Studies 2 and 3 were performed. 
Table A3: Lux response (RLU values) of P. putida KT2440 biosensor to P123 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables P123 (A), (B), 
(C) and (D), respectively 
P123(A) 
11,- c:anc.tnltlan" 
0 0.1 0.25 o..s 0.75 1.11 
1 2 3 Avs- 50 1 2 3 ~ SD 1 2 3 Avs- SD 1 2 3 --SD 1 2 3 Avs- 50 1 2 3 ~ 
1 107.1 108.0 107.9 107.7 0.' .ua 148.7 40" 4711 ?.'.! 272 27.8 27.1 27.4 0.4 188 18C 18 18.~ ill.4 17.2 14.4 14.1 15.4 1.5 111.1 15.8 153 168 
10 67.4 84.3 69.0 73.6 ~~ 38.9 31.( 36.7 35.5 4.1 17.8 18.2 17.4 17.8 0.4 12.0 11.J 12.( 1U 02 9.8 9.9 9.8 9.8 0.0 8.1 8.8 8.8 8.6 
20 57.3 56.1 59.7 57.7 H 35.6 35.7 33.2 34.8 1.4 17.3 16.7 16.5 16.9 0.4 12.1 1U 12. 1U 0.4 11.9 9.7 9.1 10.5 1.2 U 7.8 9.2 8.7 
30 45.7 49.2 52.3 49.1 ll., 29.7 27.5 30JI 29.3 1.8 15.1 14.3 14.5 14.6 0.4 10.0 9.0 9.3 9.4 05 7.8 7.E 7.! 7.6 0.2 7.5 6.7 6.1 7.0 
40 39.8 35.8 47.1 40.9 5.7 22.4 16.1 19.6 19.4 3.2 13.9 13.0 12.2 13.0 0.9 7.1 7.] 8. 7.6 0.5 7.0 7.2 6.! 6.9 0.4 5., 6.0 6.5 8.1 
so 41.3 42.6 41.9 41.9 0.7 268 1271 20.~ 24.9 3.6 11.1 10.8 10.7 10.9 0.2 8.2 7.8 8. 80 111.4 6.5 6.1 6.1 6.2 0.3 6.1 47 4.8 4.8 












0 0.1 0.25 o.s 0.75 1.0 
1 2 3 A ... 50 1 2 ill " ... so 1 z 3 A.._ so 1 2 ll """ SD 1 2 3 A.._ so 1 2 3 " ... SD 
1 421.7 ~27_g 407.6 419.1 10.• 358.5 ......,7 3673 --~ 1,, 201.7 231.C 235.8 222.8 18.! 88.5 92. 83. ... 4.5 47.7 48.5 49.t 48.6 0.9 33.1 30.[ 30.2 31.1 1.7 
1n 399.5 13TT.5 346.5 374.• ?<:.E 386.5 3311 1,--,,._ ~Q i-..-..E 149.S 207.8 212.4 190.0 34.1 86.4 1M.l 106.' Q7. 10.1 60.8 71.1 74.1 68.7 7.0 ••2.9 123.~ 2.7 :23_1 20.1 
20 2n.4 244.5 242.4 254.e 19.E 1577 
,.,.,. .~ .... , 164.S 149.3 13'.1 149.4 15, '7QQ a,.1 Q7' GU Q,: 67.1 7?Jt 66.! ,:an 3.3 -· I ,:n" .... l,:n<1 09 
ao 1n.2 170.S 171.5 173.1 3.6 13'3 '1711 172.• 159.3 171.• 88.3 90.9 85.2 88.1 2.9 74.4 70.JI 7'11 17'1.4 18 54.3 43.! 56.9 51.6 7.1 410 40.S 397 403 0.6 
40 134.1 113.◄ 124.7 124.1 10.◄ 85.5 107.4 90.9 94.6 11.4 70.1 78.0 79.7 75.9 5.1 63.9 65.6 57.0 """ 4.6 47.9 54.9 51.C 51.3 3.5 3&.< 45.1 39.4 41.0 3.6 
so 102., 115.3 100., 106.[ 81 70.2 1--. ""'" AJt" 1 .... 51.2 =n S6.3 54.5 '>Q AAn ...... .... ~- "" <In. """ 39.3 36.0 48 -.a, ..nc 401 ..n, 1.0 
60 113.3 1"'> 111.E 115.S 5.S ""n laa<1 .. ~ ·-~ ~~, 571 589 67.6 612 "" ..... .. 7.,_ ""n 1481 ... 48.2 39.4 416 424 S.5 ...... 1 .... ..... "' . 2..C 
P123(C) 
- ~" 
0 0.1 0.25 G.5 0.75 1.0 
1 2 3 A.._ so I z 3 " ... so l z 3 A.._ so 1 2 , l"WS so 1 2 ll A ... so I 2 3 " ... so 
I 281.1 285. 271.8 1279.4 6.9 239.0 255.1 2«• 1>48.3 8.2 134.~ 154.0 157.2 148.E 12. 69.0 61.1 55} ~.I 3.0 31.8 32.3 33.( 32.4 0.6 22.1 20.C 20.1 20.7 1.2 
10 266.3 751.1 231.0 1249.E 17.I '157.D 271 "1!i.• nsa1.• .,.,_, 99.9 138.5 141.6 126.123 66.9 67.: 70.E lu.1 71 40.5 47.4 49.4 45.8 4.7 ?SR 16.' 18 1!i . .C 1".4 
)0 184.g 163.1 161.6 1169.~ 13. 1ns., 147' <AD_< ....... '1A < 109.1 99.5 89.4 99.6 10. 5.~.3 in.! R4.' 
..,. 
84 44.8 48.5 44.f 46.0 2.2 3?.< 1..-._, l'.34.0 1 .... ., nc 
30 118. 113. 114.3 1115.4 2.4 89.8 114.1 ~14-' 106.2 ~4.• 58.9 60.6 56.8 58.8 1.9 49.6 47.2 48.1 i.11 1.2 36.2 29.C 37.9 34.4 4.7 27.3 26.1 26.5 126.9 0.4 
40 89.4 75.6 83.2 82.7 6.9 57.0 71.6 60.6 83.1 7.6 46.7 52.0 53.1 50.6 3.4 42.8 43.7 38.0 141.• 3.0 31.9 36.6 34.( 34.2 2.3 25.E 30.1 26.3 27.3 2.4 
50 68., 76.9 67.C 70.7 5.4 46.8 65.5 64.2 58.8 ~o., 34.1 37.4 37.5 36.3 1.9 36.6 30.2 30. 32~ 3.7 20.: 25.5 26.2 24.0 3.2 28.0 27. 27.:l 26.8 0.7 




0 0.1 0..15 o..5 0.75 1.0 
1 z 3 ,. .. 50 1 z 3 ,. .. so 1 z 3 ,..., 50 1 2 3 l""S so 1 z 3 ,. . _ SD 1 z 3 ,. .. so 
1 15.8 64.7 66.0 48.8 28.E 39.1 37.1 381 382 1.0 27.1 27.5 29.5 28.0 1.3 20.5 22 20.,121 0.11 16.3 18.6 20.8 18.6 2.3 15.8 17.1 17.1 16.8 1.1 
10 64.9 77.9 68.0 70.2 6.8 66.6 68.'l 68.• 57.6 1.8 40.6 39.9 38.1 39.6 1.2 28.7 3CL 31.f M 1.6 27.4 26.3 27.4 28.7 1.3 20li 177 .• 120.a 121.2 0.9 
20 66.7 94.7 87.6 82.7 15. 58.3 62.9 58.6 69.9 2.6 45.1 47.6 46.2 46.3 1.3 12.3 4U 34,C ba, 14.! 28.3 32.1 34.: 31.5 3.0 24.C 28.! 28.4 27.0 2.8 
30 77.1 86.4 93.2 86.2 8.0 70.5 6U 74.1 70.8 l'.'16 63.1 61.4 48.8 51.1 2.2 41.6 371 '"" 1 137.1 33 28.8 33.1 3<4.2 32.0 2.9 75.1 m, 24.7 176.5 7.8 
40 89.8 96.0 94.0 93.2 3.2 67.2 82.4 74.7 88.1 82 60.9 48.2 41.9 47.0 4.6 8.8 3H 35.' r.>5,1 14..! 35.0 31.8 26.l 31.1 4.3 29• 24.! 23.8 26.0 2.9 
50 101.7 1115.! 108.8 ho8.l 6.9 78.3 79.5 79.5 79.1 0.7 57.7 61.9 60.5 60.1 22 45.1 4U 38.E 141.C 4.3 30.8 37.5 34.! 34.4 3.4 28J 26.• 26.6 282 0,7 
"" 134.• 120. 128.9 128.1 7.0 11.4 Q 89.4 IIWIA 93.5 13.7 802 72.2 no 748 4.7 51 "". "qa lo<q• 15 141.2 39.7 43.9 41.6 121 31.9 l?CIR 131.5 131.0 1.2 
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Figure A6: % RLU relative to control for defined concentrations of Pluronics P123 at 10 




Pluronic P84: RLU vs. Time graph 
Treatments LoglO %RLUat 
P84 Cfu.Jml 60min 
Con1rol 9.3:l0.5 I 00.0:10.9 
0.1% 10.6:l0.1 63.8±1.0 
0.25% 11.3:l0.5 51.2±1.1 
0.5% 12.3±1.6 41.3±0.6 
0.75% 13.3±03 32.7:lO.l 
A T,me(ll'nn) 1.0% 13.0:10.6 32.2:l0.2 
1- 0 • P84 a I -~:-s. 
1000 • s 
Treatments LoglO %RLUat 
P84 CfuJml 60min 
00'"'<' 
•10 Control 9.0±03 100±0.9 
0.1% 10.5:lO.l 46.0±1.0 
0.25% 11.7±0.2 32.4±1.1 
0.5% 13.5±0.7 11.4:l0.6 
0.75% 13.5±03 IO.HO.I 
1.0% 12.5±0.4 9.7±0.2 
Treatments LoglO %RLUat 
P84 CfuJml 60min 
Con1rol 9.6±0.1 100±0.0 
0.1% 8.7±0.2 106.7±7.9 
0.25% 10.6±0.6 66.7±2.2 
0.5% 12.6±0.4 72.7:l0.9 
0.75% 113±0.5 69.1±1.5 
C 1.0% 10.5±0.2 68.1±1.0 
Figure A7: Lux response of P. putida KT2440 biosensor to P84 Pluronic at defined doses 
(mg/L). Changes in Lux output relative to control and cell culturability after 60 min of 
treatment are shown. (A) Data from Study 1 performed on 1-14-2009, (8) Study 2 performed 
on 12-23-2008, (C) Study 3 performed on 1-16-2009. Means of analytical replicates and 
standard errors are shown for each study. All the three studies with Pluronic P84 were 
performed within 2 months of its receiving from the supplier. 
Table A4: Lux response (RLU values) of P. putida KT2440 biosensor to P84 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables P84 (A), (B) 
and (C), respectively 
P84 (A) 
,_ ~" 
0 D.1 0.25 0..5 0.75 LIi 
1 z 3 Avs. so l z 3 ""-- 5D l z 3 Aws. so l 2 3 A,.. so l z 3 Avs. so l z 3 
t 173.0 172. 171.2 1172.1 0.9 1U.? ...... •4?.I 1141.1 31 100.4 93.9 91.4 952 4.7 170.7 66.~ ..., ""·' 1-,-, 53.8 52.4 48.1 51.4 3.0 4.a1 .... _,...,., 
10 119.7 110.1 112.0 114., 4.8 87.8 71. 89..2 89.5 2.1 48.9 48.3 46.8 48.0 1.1 35.8 33.7 34.1 ~~ 1.0 30.5 24.7 27.4 27.5 2.9 27.2 27.S 26.3 
20 65.8 62.3 60.1 62.7 2.9 44.6 43.1 44.9 44.2 1.0 34.8 35.2 36.9 35.6 1.1 25.5 2U 28.' ""·' 1.7 22.6 21.6 19.3 212 1.7 20.1 18.e 18.0 
30 54.8 59.8 62.! 59.2 4.1 43.4 43.7 45.1 44.1 0.9 31.3 31.3 29.7 30.8 0.9 21.4 23! 25.' ""-~ 2.0 20.9 23.3 23., 22.5 1.4 20.! 22.e 24.5 
40 41.5 43.8 51.6 45.7 5.3 32.9 30.4 33.4 32.2 1.8 28.8 30.6 30.8 30.1 1.1 25.7 26.1 25.1 "".1 o.e 23.2 23.9 2U 23.0 1.1 18., 2U 21.0 
50 42.9 44.3 44.0 43.7 0.7 31.5 32.! 31 4 31.8 0.8 25.8 25.9 23.3 25.0 1.5 187 'JO.< 17.1 18,1 1.1 16.1 16.5 15.6 16.1 0.4 14.11 1U 14.2 
fit) 41.1 34.8 36.0 37.3 3.4 "JC_O -,n ?A 0 I.,.. A ?7 18.5 18.7 ?O.? 1R 1 0.9 UC ... . , 1C r •r lno 1:>.R 11 7 121 17.:> 0.6 . ., ... 11 C 
P84 (8) 
,_ ~" 
0 0.1 0.25 0..5 0.75 LIi 
1 z 3 Aws. SD l z 3 A .. 5D 1 2 3 Aws. so 1 z 3 ~ so l 2 3 Aws. so l z 3 
1 107.1 108.( 107.9 107.7 0.5 22.9 122.8 24., 23.2 0.8 16.4 16.( 16.! 16.3 0.3 1,~ 1? '. 10.1 11.I 1.3 11., 11.2 11.3 112 0.1 8.4 8. Al 
10 67.4 84.3 69.0 73.6 9.3 20.7 21.0 21.7 21.2 0.5 14.7 14. 14.! 14.6 0.3 12.8 1V 12.1 nv 0.4 11.0 10.7 11.0 10.9 0.2 8.8 9.3 9.8 
20 57.3 56.1 59.7 57.7 1.8 21.1 22.0 20.4 21.1 0.8 14.7 15.0 14.8 14.8 0.1 12.5 12.1 12.~ 1V 0.2 10.3 10.1 10. 10.2 0.2 8. 8.7 8.8 
30 45.7 49.2 52.3 49.1 3.3 18.1 20.4 22.5 19.7 3.3 15.0 14.0 13.7 14.2 0.7 10.5 10.! 11.1 110.1 0.3 9.1 9.4 9.6 9.4 0.3 7.1 7.5 8.4 
40 39.8 35.8 47.1 40.9 5.7 18.3 22.7 2U 21.2 1.7 13.7 14.0 13.9 13.8 02 11.5 11.5 11.3 111 ! 0.1 9.9 10.0 9.5 9.8 0.3 7 7.9 7.8 
50 41.3 42.6 41.9 41.9 0.7 21.1 21., 21.E 21.4 0.3 12.9 13.3 12.9 13.0 0.2 102 10.1 10.~ no.: 0.2 8.4 8.7 7.8 8.3 0.4 72 7.2 7.2 
60 40.7 39.3 41.1 40.4 0.9 18.5 10• 171 18.8 10 12.0 14.1 13.2 13.1 1.1 4.1 ~ .. 5.2 IAA n.s 41 41 4., 4.1 0.1 4 38 ..... 
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P84 (C) 
,_ c.- .. -" 
0 0.1 0.25 o..5 0.75 1.0 
1 z 3 ...... so I z 3 ...... so 1 2 3 ...... so 1 2 3 "'"' so 1 2 3 "'"'· so 1 2 J " ... so 
I 80.6 81.2 79.8 80.5 0.7 50.1 50.4 46.5 49.0 22 65.7 61.1 48.8 58.5 8.7 58.l 55) 53 cc 1.7 53.• 54.4 51. 53.0 1.7 38' hu,.J 40.0 38.2 2.9 
10 60.2 60.5 59.9 60.2 0.3 62.3 60.C 54.1 58.9 4.0 54.3 46.1 50.4 50.3 4.1 1 ..... 4 33.• 21. i. .. , i...,_, 35.8 37.4 35.3 36.2 1.1 h1.4 '"1.1 I~.• 37.li 1 7 
20 43.5 42.1 40.9 42.2 1.3 25.6 13.S 26.9 22.0 7.4 32.4 31.1 30.0 31.2 12 26.2 22., 26.l 125.< 2.4 25.6 25.9 23- 24.9 1.4 24.' 24.• 23.3 23.9 0.6 
30 36.0 35.4 33.4 35.0 1.4 31.B 31 R 35.9 I '.1'.'1.1 1,_4 20.6 23.B 23.3 22.6 1.7 24.4 ,.._. ,i;_. i,4_, 1.n 22.0 21.9 20.< 21.6 0.6 
.,.,. 22.1 ?1.4 21.9 04 
40 38.2 21.5 38.3 32.7 9.7 35.7 22.4 23.2 27.1 7.4 18.7 20.9 20.9 20.2 1.2 20.4 20.! 22. i,1_ 1.0 19.5 112 20.6 17.1 5.1 20.4 20.• 19.8 20.4 0.6 
50 21.5 31.3 26. 26.3 4.9 30.1 22.3 19.1 23.8 5.7 20.1 19.4 21.1 202 0.8 19.9 19.f 16.1 ~8.1 1.7 19.6 17.0 21.E 19.4 2.3 18. 2P 20.5 20.1 1.3 
60 2R.2 26.4 22.3 ?5.6 3.n '>An ?7 ~ "" 1-,cc 17 ?1.3 17.6 17.' 18.8 22 .,, .. 1,1 n 10 r ..... -.. 19 0 ?1, 18.S 19.5 1.5 -,n I 1D 1RQ 111? 1.0 
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Figure AS: % RLU relative to control for defined concentrations of Pluronics P84 at 1 O 




Pluronic L92: RLU vs. Time graph 
Tffldmeots LoglO %RLUat 
L92 Cfulml 60min 
Control 9.3:i0.5 100.0:i0.9 
3 0.1% 12.2±0.1 95.7±1.0 
CZ: 
0.25% 12.7±0.5 91.8±4.9 
O.S% 12.8±1.6 75.3±6.7 
0.75% 12.2±03 78.0±6.0 
A 1.0% 12.5±0.6 78.6±10.3 
Tretdmeots Logl0 %RLUat 
L92 Cfulml 60min 
Control 9.2:t0.1 lOOiO.O 
0.1% 11.0i0.3 78.7±3.l 
0.25% 12.7±0.9 77.0±4.9 
0.5% 12.9±0.6 165±6.1 
0.75% 12.0:i0.5 71.9±6.0 
B T,me{m111) 1.0-/4 11.2±0.2 80.9±133 
7 
900 • 
800 L92 • 1 
Treatments Logl0 %RLUat 
L92 Cfulml 60min 
■ O:!S 
■ O!r 
Control 9.2±0.8 100:l:3.9 
0.1% 10.7±0.2 77.7±4.1 
0.25% 10.8±0.4 63.5±23 
0.5% 133±0.l 74.9±1.7 
0.75% 13.2±0.2 64.6:tl.7 
1.0-/4 13.li0.3 35.1±2.2 
Ttmlments LoglO %RLUat 
L92 Cfulml 60min 
Control 9.2±0.0 100±0.7 
0.1% 11.7±0.2 653±0.4 
0.25% 103±0.3 62.7±0.6 
0.5% 11.3±0.1 39.3±0.2 
0.75% 11.2±0.2 26.7:iO.l 
D Time(mon) 1.0-/4 12.1±0.3 213:i0.3 
Figure A9: Lux response of P. putida KT2440 biosensor to L92 Pluronic at defined doses 
(mg/L). Changes in Lux output relative to control and cell culturability after 60 min of 
109 
treatment are shown. (A) Data from Study 1 performed on 2-25-2009, (B) Study 2 performed 
on 2-24-2009, (C) Study 3 performed on 2-28-2009, (0) Study 4 performed on 2-21-2009. 
Means of analytical replicates and standard errors are shown for each study. All the three 
studies with Pluronic L92 were performed within 2 months of its receiving from the supplier. 
Table AS: Lux response (RLU values) of P. putida KT2440 biosensor to L92 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables L92 (A), (B), 
(C) and (0), respectively 
L92 (A) 
,_ ~" 
0 0.1 0.25 IU 0.75 UI 
I z 3 A ... so I 2 3 A ... so I 2 3 A ... so I 2 3 -so I 2 3 A ... so I 2 3 A,.. 
l 124.0 118. 120.6 1121.1 2.7 86.1 821 86.1 84.8 1.8 92.4 922 97. 93.9 2.8 81.1 906 87." DA_f 4.11 91.9 90.7 93.~ 92.0 1.3 71.1 72.1 741 72.9 
10 118.0 119.1 121.C 119., 1.5 97.7 84.0 85.4 89.0 7.8 82.8 89.3 84.8 85.6 3.3 74.8 73.J 75. 7,U 1.0 73.6 74.8 74.1 742 0.6 55.1 39.S 54.8 50.1 
20 119.1 120. 103.8 114.< 9.2 81.8 78.( 85. 81.6 3.5 72.0 72.1 80.( 74.7 4.6 89.1 87.4 91.7 66., 4.2 63.6 63.1 68.2 64.9 2.8 48.1 49.! 52.2 49.7 
30 101.7 102.! 108.f 1104.' 3.6 74.8 71.1 91.2 79.0 10. 70.0 67.7 68.3 68.7 1.2 70.8 85.E 68. 87..! 2.8 60.4 63.0 74A 65.9 7.4 53.< 47.7 58.4 53.1 
40 94.1 101. 97.3 97.6 3.6 81.1 75.1 76.! 77.5 3.1 61.9 68.3 sa., 62.9 5.1 85.! 80.8 64.8 63.E 2.5 72.2 79.4 68A 73.3 5.6 53. 55. 52.4 53.8 
50 81.3 79.8 83.I 81.7 2.1 80.2 59.1 68.6 82.8 6.1 52.2 53.3 44.5 50.0 4.8 41.1 54.! 46.1 47.~ 6.8 57.8 62.2 65.B 61.9 4.0 60. 4H 68.6 62.6 












0 0.1 0.25 o.5 0.7S u, 
1 2 3 ...... so 1 2 a A,.. SD 1 2 3 A,._ so 1 2 9 ..... so 1 2 3 A,._ SD 1 2 I ...... SD 
1 96.1 91.1 92.3 93.1 2.6 78.0 69.3 73.• 73.6 4.3 49.2 49.8 45.4 48.1 2.4 71.4 80.6 83.1 78.! 8.4 70.• n., 72.5 71.7 1.1 49.1 52.7 80.8 64.2 8.0 
10 80.9 72.0 69. 742 5.9 61.3 67.1 61.6 83.3 13.3 74.4 83.7 75.9 78.0 5.0 163.3 70.1 62. AA• 14.1 56.3 60.7 62.1 59.8 32 41 411, l~n 141.4 8.6 
20 75.0 76.6 79.5 77.0 2.3 61.0 61.! 57.• Mn I?? 66.6 742 60. 67.0 7.0 68.• 68.0 162'1 ..... ~122 55.1 56.4 55.1 55.7 0.7 ..... •1.1 49.9 I.CS1 43 
'Ill 68.9 71.2 74.9 71.7 3.1 50.6 45.3 64.8 !i3.8 110. 50.5 55.5 54.4 53.5 2.6 .C7.6 f>T.• 55.' ""'. Is, 45A 392 44.3 42.9 3.3 ...... '17.5 4'.>.ll 38.1 3.7 
40 69.1 68.7 66.5 68.1 1.4 41.4 51.C 48. 47.0 5.0 40.8 50.7 48.1 46.7 52 43. 54.7 49.0 49_; 5.5 52.3 47.6 41. 47.1 5.6 36.' 36.• 38.9 372 1.5 
so 59.7 61.6 64.! 61.9 2.4 4'42 492 49.8 47.7 3.1 41.3 522 40.9 44.8 6.4 42.0 .C5.E 49.' "-'-J 3.8 31.8 40.1 40.5 37.5 4.9 35.1 3-U 36.8 35.5 1.4 
"" 60.5 608 60.8 60.7 0.2 45.6 ..,.n 51.1 47.6 13.1 41.1 47 8 507 4"" 14.9 ...... o:? C .... .a, IA7 -.A• ,.--,n 50.1 43.5 6.0 l'tAI. 47• R-.n 1 .. on 1-. .. 
L92 (C) 
TI,- Can:wltrallcm" 
0 0.1 0.25 0.5 0.75 1.0 
1 2 3 A ... so 1 2 J ...... so 1 2 3 A,._ so 1 2 s A.._ SD 1 2 3 A,._ so l 2 J ...... so 
1 81.0 81.2 80.9 81.0 02 89.0 712 70.3 70.2 1.1 54.5 55.4 51.0 53.7 2.4 .C1.0 «.5 432 42., 1.8 44.4 40.1 40.9 41.8 2.3 39.0 35.f 36.5 37.0 1.8 
10 72.3 70.5 732 72.0 1.4 66.0 85.7 180.2 84.0 ... , 51.0 49.1 49.0 49.7 1.1 34.5 .u; 1 41.4 40.~ 16.4 35.7 40.1 35.7 37.1 2.6 28.11 1311.C 30.1 ?Q7 07 
20 65.9 61.0 64.3 63.7 2.5 """ 800 1 ...... 161.1 2.0 45.9 45.9 41.0 44.3 2.8 333 310 21.n ?A .• 6.6 29.0 31.0 25.7 28.5 2.7 30.11 130.C 21.2 ?7A 5.3 
~o 56.9 63.4 632 61.2 3.7 117.1 55.6 512 58.3 '6.5 39.0 38.0 36.4 37.8 1.3 30.0 311.D 78.8 ?GO 07 30.0 28.9 27.6 28.8 1.2 243 22.1 19.1 ?1.8 ,.e 
40 56.0 54.3 49.1 53.1 3.6 45.3 4'4.5 52.3 47.4 4.3 31.0 32.2 31.0 31.4 0.7 30.0 31.0 32.2 31.1 1.1 30.0 31.0 322 31.1 1.1 222 21.C 18.9 20.7 1.7 
so 50.0 45.9 41.0 45.6 4.5 40.0 35.5 36.7 37.4 2.3 25.7 22.4 20.0 22.7 2.8 31.0 312 29.0 30A 12 24.4 212 20.1 21.9 2.3 18.9 15., 12.2 15.5 3.3 
60 41.0 36.0 33.2 36.7 3.9 .... , ?7n I""' ?A'- 4.1 i21.0 ?'-7 23.3 23.3 12.3 ?0:7 29.1 no ?7! 117 .,.,., ., .. " 25.5 23.7 1.7 1'- .. 11?0 111 1?0 22 
111 
L92 (D) 
11 .. ecn.ntr.lkln" 
0 0.1 0.2.5 0.5 0.75 1.0 
l 2 3 Avs- so 1 z J --so l 2 3 Avs- so 1 z a ~· so l 2 3 Avs- so 1 2 J Avs- so 
1 81.0 81.0 82.0 81.4 0.6 13.3 11.6 10.4 11.8 1.4 14.6 15.4 16.1 15.4 0.7 13.4 14.! 15.A 14.< 1.0 12.0 12.3 13.> 12.5 0.6 9.110~ 10.7 10.3 0.5 
10 34.8 31.7 33.2 33.2 1.6 21.8 26.3 24 23.9 1.9 16.6 12.8 15.4 14.9 2.0 9.2 7.1 6.E 7.5 1.8 6.4 5.8 5.2 5.8 0.6 4.6 44 4.4 44 0.1 
20 23.9 22.5 23.2 23.2 0.7 14.0 138 14.6 14.1 0.4 9.6 10.3 10.6 10.2 0.5 7.2 6.1 7.117.0 0.2 4.7 4.6 4.E 4.6 0.1 3.1 3.6 41 39 0.2 
"" 17.7 19.5 18.~ 18.7 0.9 17.3 12.0 123 17.2 lo? 8.8 9.8 9.7 9.4 0.5 57 5.1 5.E 1".A 01 3.9 4.0 3.~ 3.9 0.1 3.< 3.6 3.6 3.5 01 
40 19.1 18.7 18.4 18.7 0.3 10.9 1U 11.1 11.3 0.4 8.8 9.2 10.E 9.6 1.1 6.1 7.2 6.4 6.7 0.4 4.3 4.1 4., 4.2 0.1 3.! 3.8 3.5 3.5 0.0 
50 13.8 16.9 14.8 15.2 1.6 10.1 9.C 10.: 9.7 0.7 8.1 8.2 7.9 8.1 0.1 4.3 5. 5.l 5.1 0.7 3.9 3.7 3.9 3.9 0.1 3 3.3 3.2 3.2 0.1 
60 15.5 15.4 14.2 15.0 0.7 9_7 10; a• QA ID . .C 8.7 9.8 9. 94 0.6 "' "A 6.1 l"a n? 3_9 4 1 3.~ 4.0 01 ?I .. 'I? 3.2 D.3 
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Figure A10: % RLU relative to control for defined concentrations of Pluronics L92 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 
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11.Si-0.2 83.9±0.8 . 
iosensor to P104 Pluronic at defined Figure A11: Lux response of P. putida KT2440 b 
doses (mg/L). Changes in Lux output relative to 
of treatment are shown. (A) Data from Study 1 pe 
performed on 1-26-2008, (C) Study 3 performed on 
control and cell culturability after 60 min 
rformed on 2-11-2009, (B) Study 2 




2009. Means of analytical replicates and standard errors are shown for each study. All the 
three studies with Pluronic P104 were performed within 2 months of its receiving from the 
supplier. 
Table A6: Lux response (RLU values) of P. putida KT2440 biosensor to P104 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables P104 (A), (B), 
(C) and (D), respectively 
P104(A) 
........ ~" 
0 Cl.I Cl.25 o.s 0.7S LO 
1 2 3 AYS, so l 2 s ...... so l 2 s Avs, so l 2 s Avs, so 1 2 s A ... so l 2 s ...... 
l 155.7 174.5 171.7 167.3 10.1 102.7 166.7 161.C 1.:1.1 36. 141.5 165.3 139.7 148.B 14.3 134.1 122.2 115.! 1-no 9.4 104.1 111.1 109.1 108.1 3.6 105.11 102.1 108.S 105.4 
10 138.3 139.1 133.8 137.1 2.8 100.6 110a 106.C 105.~ 4.9 92.9 98.6 87.1 92.9 5.7 92.5 97.1 94.7 114.8 2.3 72.4 82.8 82.1 79.1 5.8 86.6 77.6 73.7 79.3 
70 114.8 143J! ...11.!!J!.. 126.1 15.S AAn inn ""' ""n ,.n 76.6 AA.? R."·" 82.8 ".8 R1? 
_,. 
•• n •• a •n ........ , . 66.4 10.n 90 1 ...... ,., n ~ .. .... 
30 114.8 137.5 136.8 129.7 12.S 64.1 972 87.9 83.1 17. 77.1 68.7 71.8 n.s 4.3 78.0 73.9 77.5 76.5 2.2 64.3 61.7 65.7 63.9 2.0 617 64.9 66.0 64.8 
40 118.5 118.6 108.1 115.1 6.0 79.5 85.7 86.11 84.0 3.9 63.4 n.4 86.0 73.9 11.◄ 112.6 80.1 75.0 79.2 3.11 57.0 70.7 67.2 64.9 7.1 411.7 56.8 56.9 54.1 
,;n 11n.• 120.5 112.0 1144 5.4 ...... A'7'1 •nn• A711 <?• "" ... 76.5 77.8 81.6 7.6 111 .. - DOC 7<>_7 laa 7n4 7n4 70.R '7n C n, an ..... -.n ■ ,...,. 











11 ... c..--" 
0 0.1 0.25 Cl.5 0.75 1..0 
1 2 3 A,._ so l 2 3 
"""' 
so l 2 3 A,._ so l 2 , A"I- so 1 2 3 A,._ so l 2 3 """' 
so 
1 31.0 30.3 31.2 30.9 0.5 16.1 16.4 17.5 16.7 0.7 17.9 18.9 18.5 18.4 0.5 17.4 19.8 19.4 18.9 1.3 13.8 15.9 15.4 15.0 1.1 14.2 15.4 14.6 14.7 0.6 
10 21.5 20.8 22.5 21.6 0.8 1'1.3 12.3 11.4 12 '.'I 0.9 11.3 12.0 11.5 11.6 0.3 10.'.'I 17.8 109 11 .. 17 10.8 10.0 8.8 9.9 1.0 D? A.7 11.0 100 no 
20 17.1 17.5 16.9 17.2 0.3 9.5 10.0 9.7 9.7 0.2 7.8 8.6 8.2 8.2 0.4 7.9 81 8.3 8.1 0.2 8.6 9.2 8.7 8.8 0.3 on A7 111.1 91 09 
"° 14.0 13.9 15.0 14.3 0.6 11 7 111.5 11.7 11 3 1117 10.2 10.3 9.7 10.1 0.3 A.5 8.3 87 B.5 0.2 7.2 8.0 7.6 7.6 0.4 10.11 9.4 9.11 QQ 11.7 
40 17.5 16.0 16.8 16.8 0.7 11.4 10.5 12.0 11.3 0.8 9.9 9.9 9.1 9.6 0.4 9.3 10.2 10.3 9.9 0.8 6.6 7.5 7.6 7.2 0.6 8.9 9.8 8.2 9.0 0.8 
Sil 15.1 14.2 15.6 15.0 0.7 9.4 9.9 11.5 10.3 1.1 8.3 8.6 9.2 8.7 0.4 7.1 7.6 7.9 7.5 0.4 6.8 7.9 8.6 7.8 0.9 8.7 8.9 9.6 9.1 0.4 
60 12.3 14 7 13.5 13.5 1.2 8.7 9.7 9.3 a, In,; 8.8 9.5 10.6 9.6 0.9 1n? AQ 10? QA i0.7 70 7.5 7.3 7.3 10.3 AA an 7!1 D .. lno 
P104(C) 
11- ~" 
0 0.1 0.25 o.s 0.75 1..0 
1 2 3 Aws. so l 2 3 A ... so 1 2 3 A,._ so l 2 3 A"I- SD l 2 3 A,._ so l 2 9 A"I- SD 
l 50.8 54.1 44.2 49.7 5.1 49.0 47.9 51.1 49.3 1.8 42.2 35.6 35.4 37.8 3.8 25.4 33.l 31.1 !I0.3 4.4 23.7 29.0 27. 26.6 2.7 27.• 29.1 25.5 27.3 1.8 
10 39.2 32.2 45.9 39.1 6.8 3119 31UJ .36.0 37.8 25 26.5 33.0 29.3 29.6 3.2 25.5 TU 35.1 29.3 5.0 32.1 32.1 32.0 32.1 0.1 31.4 127.4 26.1 128..3 2.8 
20 28.2 32.4 31.2 30.6 2.2 31 A 31.4 28.1 30.5 2.1 23.7 27.0 20.6 23.8 3.2 1A '- 22. ,.. 23.7 57 16.9 24.1 2V 21.2 3.8 29A 23.8 28.3 284 2.9 
30 22.2 22.0 28.9 24.4 3.9 19.9 19.1 79.f 23.1 5.8 16.3 17.6 22.8 18.9 3.4 17.2 18. 35.6 23.0 10.1 14.2 19.9 23. 19.1 4.6 17.E 18.5 23.4 10 II ".1 
40 28.8 24.3 19.3 24.1 4.8 14.4 19.9 21.3 18.5 3.7 12.6 21.4 22.4 18.8 5.4 31.2 17.1 18. 22.6 7.5 15.4 20.1 24.! 20.1 4.7 20 20.0 19.8 19.9 0.3 
50 25.4 26.0 22.9 24.8 1.7 16.8 21.6 19.8 19.4 2.4 23.8 22.0 13.2 19.7 5.7 14.9 22.' 16.4 17.9 3.9 20.4 24.5 20.3 21.7 2.4 15.7 19.5 21.1 18.8 2.8 




0 0.1 0.2.5 CLll 0.75 1.D 
1 2 3 ,. .. so 1 z 3 ,.,._ so 1 2 3 Avs. SD 1 z ll 11,.._ 50 1 2 3 A ... so 1 z , A"S- 50 
1 78.0 71.7 71.3 73.7 3.8 512 55.S 612 56.0 5.0 58.0 59.1 63.3 60.1 2.8 55.8 38.3 45.7 46.6 8.8 41.9 44.7 45.6 44.1 1.9 44.1 43.6 372 41.6 3.8 
10 66.1 65.6 69.0 66.9 1.8 46.4 52.6 55.9 51.6 4.8 49.4 43.8 46.8 46.7 2.8 49.9 62.4 50.8 61.0 1.3 50.2 51.1 52.9 51.4 1.3 46.0 406 45.0 43.6 12.8 
20 55.2 51.3 56.9 54.5 2.9 41.8 45.9 41.1 42.9 2.8 39.0 39.7 38.3 39.0 0.7 45.2 49.5 47.3 47.3 2.2 47.7 48.0 53.4 49.7 3.2 38.0 42.1 432 41.1 2.7 
30 53.3 52.3 51.1 52.2 1.1 370 43.9 43.6 41.6 3.9 41.4 42.8 43.6 42.6 1.1 53.7 50.9 58.8 54.4 3.9 562 57.4 54.4 56.0 1.5 44.6 47.9 40.0 442 3.9 
40 57.0 57.2 57.2 57.2 0.1 43.0 41.8 44.4 43.1 1.3 35.8 38.7 38.4 37.6 1.6 53.3 47.S 55.4 52.1 4.1 55.0 54.1 54.4 54.5 0.5 46.1 42.8 51.2 48.7 42 
50 63.2 64.4 68.9 65.5 3.0 50.5 43.7 47.7 47.3 3.4 51.4 58.0 57.1 55.5 3.6 40.0 40.7 47.6 42.7 42 60.2 54.4 56.1 56.9 3.0 48.4 48.7 46.1 47.7 1.5 
60 53.9 57.1 54.4 55.2 1.7 .. ,., AA7 474 Ai;_, :7a 39.2 38.4 431 40.7 2.5 "'"' "-'. ; ,:n A 0:-.D .. , SOR 51.5 57.9 51.8 1.1 ..... AD 1 _..,n ...... I 1 o:
120 
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Figure A12: % RLU relative to control for defined concentrations of Pluronics P104 at 
10 min intervals. Means of analytical replicates and standard errors are shown for each 
study. 































































Figure A13: Lux response of P. putida KT2440 biosensor to F88 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 1-7-2009, (8) Study 2 performed 
on 1-6-2009, (C) Study 3 performed on 1-9-2009. Means of analytical replicates and 
standard errors are shown for each study. All the three studies with Pluronic F88 were 
performed within 2 months of its receiving from the supplier. 
Table A7: Lux response (RLU values) of P. putida KT2440 biosensor to F88 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables F88 (A), (B) 
and (C), respectively 
F88 (A) 
- ~" 
0 0.1 0.25 0-5 0.75 1.0 
l 2 3 -""11· SD l 2 J .-.. SD I 2 3 Aws. SD l 2 3 .-.. SD I 2 3 Aws. SD l 2 J 
1 146.1 144.! 145.3 145.E 0.6 1111 1711 172J ~SU 35..:! 110.§ 150. 134.~ 131. 1 ?ft.( 1117,2 11H 1'"" .. .,.<DI 91.1 10U 89.5 93.9 6.4 771 72.1 79 
10 93.0 89.4 88.6 90.3 2.3 90.7 89.B 95.1 91.9 2.9 82.2 76. 72A 77.0 4.9 61.7 59.C 55.( 58.6 3.4 47.1 46.9 49.1 47.7 1.2 41.7 40.1 42.5 
20 60.5 65.0 59. 61.5 3.1 63.5 64.0 57.1 61.5 3.9 582 57.8 57.9 58.0 0.2 50.4 51..:l 591 53.7 5.0 45.0 45.6 43. 44.6 1.3 37.! 34.8 38.4 
30 58.4 57.1 59.5 58.3 1.2 59.8 58.D 58.0 58.6 1.1 58.6 50.1 55.0 54.6 4.3 432 44.1 461 44.S 1.6 40.2 442 45.9 43.4 2.9 3U 37.5 38.4 
40 58.5 58.5 57.6 58.2 0.5 59.0 56.5 55.~ 57.1 1.6 51.2 54.6 54.8 53.5 2.0 49.5 50.6 51.9 50.7 1.2 36.9 41.6 41.5 40.0 2.7 34.~ 36.7 32.6 
50 46.6 54.7 55.8 52.3 5.0 64.8 66.1 53.~ 64.7 1.3 51.9 54.1 52.8 53.0 1.1 454 45_; 46.• 45,7 07 39.5 39.9 34.3 37.9 3.1 329 1 ...... 34.9 
60 49.7 50.0 51.9 50.5 1.2 ,;ti., 5? .. .,, 1515 11 47.4 49.4 49.9 489 13 ... A AC7 144.A •• 7 11.2 3<;_A 381 37.' 371 1 1 ... 1 .. n, ..... 
F88(B) 
11 ... ~" 
0 0.1 0.25 0.5 0.75 1.0 
1 2 3 -"VII- SD 1 2 J .-... SD I 2 3 -""11· SD 1 2 3 .-.. SD 1 2 3 Aws. SD l 2 3 
1 100.1 95.6 95.2 97.2 3.1 An.II All.II IHl.t 857 4.9 68.0 70.( 77.C 71.7 4.7 ... , 66.C 68. 56.3 23 42.! 45.0 42.5 43.5 1.4 390 371 38J 
10 60.2 61.2 60.2 60.5 0.6 58.0 52.0 58.0 55.3 3.1 53.0 50.( 51.1 51.4 1.5 35.0 38.f 38.1 37.5 2.1 33.1 31.6 34.4 33.1 1.4 27.0 28.9 25.4 
20 31.0 30.6 31.! 31.1 0.6 29.0 28.S 2U 28.6 0.4 28.7 31.2 29.4 29.8 1.3 24.0 25.C 24.1 24.3 0.6 22.0 21.2 22.! 21.9 0.7 21.C 21.1 222 
30 25.0 26.7 28., 26.7 1.7 232 22.1 242 232 1.1 22.1 20.1 20.2 20.8 1.1 22.1 20.r 20~ 20.8 1.1 21.1 19.8 19.1 20.0 1.0 1U 19.9 18.9 
40 26.5 24.0 25.4 25.3 1.3 24.2 222 23.1 232 1.0 222 21.2 19.8 21.1 12 20.0 22.2 18.1 20.1 2.1 222 21.1 20.0 21.1 1.1 21.1 18.8 18.3 
so 22.0 21.0 222 21.7 0.6 ?1,1 221 19.8 1,1.0 12 20.0 19.7 19.4 19.7 0.3 194 20.0 21.0 201 lo.a 21.0 22 .• 23. 22.1 1.1 1811 17.4 164 





















0 0.1 0.25 Cl.5 0.75 1.0 
1 z 3 Avs. so 1 2 3 ""-· so l 2 3 Avs. so 1 2 3 A.._ SD 1 2 3 Avs. SD l 2 3 A,._ so 
l 95.8 95.6 9.8 67.1 49.1 n.o 79.3 7U 78.4 12 73.7 73.! 73.3 73.5 02 56.9 57., 56. 56.8 1.1 62.• 61.0 62.7 62.0 0.9 49.6 49.~ 54.• 51.1 2.8 
10 66.8 62.9 59.6 63.1 3.6 62.0 61.0 63., 62.1 1.1 57.0 61.8 58.4 59.1 2.5 54.0 61.0 48.0 61.0 3.0 42.0 41.8 45.7 43.2 2.2 36.1 36.~ 'S7 36.5 0.6 
20 412 42.0 41. 41.5 0.4 45.0 472 43.0 45.1 2.1 41.2 40.1 40A 40.5 0.6 36.7 39.0 32~ 36.0 3.4 32.~ 38.9 38.0 36.4 3.6 34.7 36.3 35.t 35.6 0.8 
30 34.1 34.9 352 34.7 0.6 396 35. 40_; 138.4 2.7 35.7 38.9 40.1 38.2 2.3 29.9 310 32.2 31.0 12 32.2 35.6 29.E 32.5 2.9 .. , 2U 33.1 31.4 12.:1 
40 38.6 38.3 38.6 38.5 0.1 30.6 43.4 43.C 39.0 7.3 38.1 41.4 38.3 39.5 1.7 29.9 30.5 36 322 3.5 29.~ 33., 30.0 30.8 2.3 322 28.4 29.0 29.9 2.0 
50 33.0 32.5 32.2 32.6 0.4 36.3 36.8 36.8 36.6 0.3 35.5 32.5 38.7 35.5 3.1 28.9 25.E 29.1 28.1 2.3 30.0 28.8 23.3 27.4 3.6 28.8 29.9 212 26.6 4.7 
t;/1 32.5 32.2 32.5 32.4 0.2 ?Q .. .... , ..,..  1-._-.n s;A 31.3 36.! 32.~ 33.6 2.7 ""n ?Al> 31.1 'Vin 1.1 31.E 240 28.ll 128.1 3.8 l?t;II 27.7 ?QI ?7r. l?n 
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Figure A14: % RLU relative to control for defined concentrations of Pluronics F88 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 
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Pluronic L81: RLU vs. Time graph 
Trealments LoglO %RLUat 
LSI CfuJml 60min 
Control 9.2:lO.0 100.0:l0.0 
0.1 % 9.9:l0.3 144.S:i:2.0 
0.25% 13.3:lO.l 118.7±3.9 
0.5% 11.4:l0.4 206.0±2.0 
0.75% 12.8:lO.0 149.8:t7.8 
1.0% 11.6:l0.2 174.7±5.0 
Treatments Log10 %RLUat 
LSI CfuJml 60min 
Control 9.7:l0.5 IOO:lO.0 
0.1% 11.4:l0.2 98.7±5.9 
0.25% 12.7±0.3 112.3±4.9 
0.5% 13.3:l0.6 233.1±15.4 
0.75% 13.4ii>.5 299.1:tll.1 
1.0-/4 11.8±0.2 209.8±1.3 
Treatments LoglO %RLUat 
L81 
LSI CfuJml 60min 
Control 9.7±0.5 100±3.5 
0.1% 11.4±0.2 169.7±1.9 
0.25% 12.7±0.3 199.3±6.2 
0.5% 13..3±0.6 199.1±8.4 
0.75% 13.4ii>.5 210.6±6.0 
1.0% 11.8±0.2 228.5±6.2 
Treatments Log IO %RLUat. 
L81 L81 CfuJml 60min 
Control 9.7±0.5 100±7.3 
0.1% 11.4±0.2 81.2±4.9 
0.25% 12.7±0.4 96.4±7.7 
0.5% 12.7±0.l 88..3±28.6 
0.15% 11.5±0.3 90.8±44.0 
fune(m1nt 1.00/4 11.8±0.2 105.8±23.0 
Figure A15: Lux response of P. putida KT2440 biosensor to L81 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 5-15-2009, (8) Study 2 
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performed on 5-14-2009, (C) Study 3 performed on 5-18-2009, (D) Study 4 performed on 2-20-
2009. Means of analytical replicates and standard errors are shown for each study. Age of 
the Pluronic L81 was around 5 months when Studies 1, 2 and 3 were performed. Study 4 was 
performed with Pluronic L81 within 2 months of its receiving from the supplier. 
Table AS: Lux response (RLU values) of P. putida KT2440 biosensor to L81 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables L81 (A), (B), 
(C) and (D), respectively 
L81 (A) 
- c.anc.tlndan" 
D 0.1 0.25 o..s 0.75 1.0 
I 2 3 A"I- 50 l 2 J A ... ID l 2 3 "•· so l 2 J A ... 50 I 2 3 A"I- 50 l 2 3 
1 81.4 84.1 87.1 84.2 2.9 70.l 702 70.3 170.4 0.3 47.0 50.5 52.~ 49.8 2.6 49.1 f.l .( 62.9 62.4 ~~ 45.8 44.1 44. 44.7 1.0 "' 7◄ 1 i,o,:-, 
10 74.7 84.5 78.1 79.4 4.9 69.9 83.4 84.2 79.2 8.0 68.4 66.0 70.7 68.3 2.4 n.1 n 64. 69.7 4.3 49.3 49.8 51.1 50.2 1.1 58.1 65.2 65.1 
20 76.2 75.7 75. 75.7 0.5 74.8 69.3 79; 73.4 3.6 so_; 73.4 75.6 76.4 3.5 65.3 61.5 75.• 67.4 7.2 s:i.; 57.! 54.8 55.3 2.4 51.1 52.4 54.8 
30 56.8 70. 69.5 65.5 7.6 67.5 69.5 74.0 70.4 3.3 62.1 72.0 69.~ 68.0 52 75.3 87.1 78.9 80.4 6.0 68.5 71.9 70.6 70.3 1.7 43.5 49.l 40. 
<40 71.1 72.2 66.9 70.1 2.8 70.7 70.1 68.4 69.7 1.2 43.0 64.1 63.• 57.1 12. 78.B 86.7 87.1 84.2 4.7 78.! 71.9 70.2 73.5 4.4 50.4 58.3 52. 
50 57.2 58.3 66.6 60.7 5.1 57.2 741 12.; 681 9.5 59.1 57.6 56.9 57.8 1.1 83.4 91U 88. 87.5 36 66.6 66.9 70.3 67.9 2.1 50.6 62.4 56.1 




















0 0.1 0.25 o.5 0.75 LO 
I 2 3 Avs- SD 1 z J ,. .. 50 I 2 3 ,. .. SD 1 2 3 ,. .. SI> I 2 3 ,. .. SD 1 z ll ,. .. 50 
1 60.9 60.9 60.9 60.9 0.0 472 58.~ 59! 552 6.9 76.6 83.7 75.1 78.4 4.6 62.1 72.1 67.6 67.3 5.0 49.8 58.7 54.3 54.2 4.5 92.9 88.8 88.5 90.1 2.4 
10 74.9 64.9 61.0 66.9 12 642 62.E 64.1 638 0.9 61.3 56.7 72.1 63.3 7.9 83.C 668 72.2 67.3 4.6 39.2 51.2 45.C 45.1 6.0 A8.f 114. ~10.1 107_1 A.1 
20 72.4 63.1 59.C 64.8 6.9 54.3 82.0 80 722 15.! 83.E 79.9 93.3 85.6 6.9 86.8 83.9 74.! 75.1 8.5 50.1 52 ... 58.3 53.8 4.0 1104.~ 132. ~3U 122.1 16.C 
'IO 70.3 59.9 59. 63.1 62 53.9 65.7 668 'liA.6 6.4 76.2 87.4 80.3 81.3 5.7 """-~ 1091 106.E 1118.C 3.4 72.6 71.9 70.5 71.7 1.0 ~6111 147.3 1n., 164.1 16.! 
40 68.9 69.8 65.5 68.0 2.3 70.1 65.1 71.1 69.1 3.5 81.1 89.1 83.• 84.5 4.1 135.1 1130.1 129.e 1132.1 3.2 108. 1107.! 83.! 99.8 14. 1 145.! 152.f ~40.! 146 6.1 
50 65.1 61.9 69.~ 65.5 3.7 84.1 75.3 n.1 72.5 7.0 80.2 88.1 86.1 85.0 42 163.1 144.1 154.E 1154.< 9.4 133., 139. 164.0 145.! 16., 1146.< 17U 11eu 159.1 112.! 
60 73.0 73.1 73.0 73.0 0.0 679 78~ "" ,72_1 .:a 84.2 76.5 85.~ 821 4.9 1, .... 117nl 1A.:• 1170' 1" "'051 1??61 223 1218.! 11 11"-.. . ..... ~61 C ....... 11.3 
L81 {C) 
--.- ~" 
0 O.J 0.25 o..5 0.75 1.0 
1 z 3 ,. .. SD 1 2 ll ,.... SD 1 z 3 Avs- SD l 2 3 ,. .. so I z 3 ,. . SD 1 2 3 ,.,._ 50 
I 50.3 52.C 50.0 50.8 1.1 28.' 28.1 28.9 28.4 0.5 33.4 37.9 39. 36.9 3.1 25. 29.4 31.1 28.6 3.0 22.2 22.9 26.1 24.0 2.6 20.! 18. 20.5 19.9 1.3 
10 48.2 45.1 49.! 47.7 2.4 39.1 JR.I 311.1 '.1112 lll.7 25.3 30.3 29.1 28.5 2.8 26 26.6 128.9 26.8 19 23.6 26.5 22.1 24.3 1.9 24. 20.~ 26.7 233 12.11 
20 42.8 33.1 48.f 41.5 7.9 28.4 31.8 31.3 30.5 1.8 39.4 37.0 42.6 39.7 2.8 27.7 28.1 28. 28.0 02 23.4 28.8 24. 25.5 2.9 24.C 24.1 26.2 24.8 12 
30 42.3 43.9 40.! 42.2 1.7 39.9 45.6 46.4 43.8 3.6 40.9 45.5 52.1 48.2 5.6 39.C 29.5 34.2 342 4.7 31.7 32.6 29.! 31.4 1.4 32.• 34.1 292 31.9 2.6 
-10 38.9 36.8 38.9 38.2 1.2 43.• 44~ 41.8 43.1 12 48.3 61.5 53.4 54.4 6.6 «.• 49.C 42.! 45.3 3.4 46.7 41.8 48.0 45.5 3.3 42.4 40.6 45.3 42.7 2.4 
50 34.3 32.2 33.3 33.3 1.0 56.1 52.6 49.4 52.7 3.4 51.7 562 52.! 53.6 2.3 501 47.7 512 49.7 1.8 50.4 46.4 50.S 49.3 2.5 52.< 48.1 492 49.9 22 




0 0.1 0.25 o.s 0.75 1.0 
1 2 3 A ... so • 2 a ""-- SD 1 2 3 A ... so • 2 , A ... SD 1 2 3 A ... 50 • 2 J -.. 50 
1 206.1 ~?«.! 223.3 1218.< 10.1 125.8 1116.! 1122..; 121.6 4.7 1113.• 128.5 131.< 124.4 9.6 91.7 106.! 109.1 102.1 9.7 85. 95.8 87.7 92.9 4.5 82.0 78.1 80.4 80.2 1.9 
lO 161, 122.1 144.< 142.8 19. 1371i Ii.An_.., ·-ft ,.~ ls.A 126.! 133.5 137.J 132.7 5.5 111,.~ 111 11'" 1113_, '.79 90.3 101.3 96.• 96.0 5.5 79, 79.1 11?11 IAO.D ., ~ 
20 144.S 156.• 149.7 150.2 6.0 95.6 129.C flnr 117.2 118.1 1O7.E 140.4 130. 126..; 16.~ 1O1.E 11111 1ner 1109_ 82 94.7 81.7 86.! 87.6 6.6 75~ 86. n.o 178.0 7.3 
30 118.2 123.( 135.f 1125.6 8.9 104.2 1117.3 11, ... 1 114.~ 9.7 95.1 120.0 1122. 112.6 l15J 85.2 104. 97~ 98.9 4.8 96.9 92.7 1O4.l 98.1 6.1 79.S 1105.1 917 92.5 12.1 
40 137.8 142. 140.7 140.3 2.3 108.3 108-5 1123.1 113.6 8.9 1108.1 122.0 142.! 124.3 17.5 109. 1 124.g 129-1 1121. 1O.f 97.6 106.6 101.! 102.0 4.5 92.4 108 97.7 99.4 8.1 
50 109., 115.1 136. 1 1120., 14.C 101.5 1112.g 88.1 1OCU 112.1 101.! 136.Q 127.C 12U 118.1 11303 107.3 118.1 1181 1H 1114.1 11U 106. 11O.g 4.4 91) 1107! 104_g 1101.• 8.5 
"" 127.7 141. 138.6 136.( 7.3 104 7 111-. 1 111?1 11n• 1 .. a 122., 135.E 135 1311 77 AH 11?1 
•A ~--?Af 97.3 98.9 174 .. 1?'1SIA4 -~ , __ ,_ •A -, 
.. 
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Figure A 16: % RLU relative to control for defined concentrations of Pluronics L81 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 
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Pluronic L64: RLU vs. Time graph 
1reatmeots LoglO %RLUat 
, 0 L64 L64 Cfulml 60min 
Control 9.5±0.2 100.0t0.3 
0.1% 11.0±2.3 61.2±1.4 
025% 11.3±2.3 85.3±1.4 
0.5% 11.5±1.2 137 .1:tlO.O 
0.75% 11.8±1.6 154.8±L2 
1'1mt-(m1n) 
1.0-/4 11.5±0.4 157.9:tl.8 
~ 0 • L64 • 1 . ~ 
Treatments Log IO %RLUat 
L64 CfuJml 60min . ~ 
0 o rs Con1rol 9.6±0.3 100±03 
010 
0.1% 133±0.3 95.0:l-0.6 
0.25% 12.3±1.5 105.4±22 
0.5% 12.5±0.6 1122±1.5 
0.75% 12 .. 0±0.9 178.7±4.0 
1.0% 12.5±02 259.9±5.9 
T-reatments LoglO %RLUat 
L64 L64 CfuJml 60min 
Con1rol 9.6±02 100±03 
0.1% 12.6±03 92.1±2.5 
0.25% 12.9±0.6 149.1±2.5 
0.5% 13.0±0.6 465.6:t{;.9 
0.75% 12.9±0.5 742.1±2.5 
1.0-/4 12.9±0.3 733.9±21.7 
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00 
Treatments LoglO %RLUat 
L64 L64 Cfulml 60min 
2500 
Control 9.5±0.5 100.0±2.6 
0.1% 11.0±2.3 89.3±12.6 
0.25% 11.3±1.8 137.5±10.4 
0.5% 12.5±1.5 164.6±6.7 
0.75% 11.8±1.0 169.8±9.2 
D Tim (min) 1.0% 10.5±0.4 165.4±5.9 
0 
Treatments Log IO %RLUat 
L64 L64 CfuJml 60min 
0 
Control 9.5±0.5 100.0i'0.3 
.j 0 
0.1 % 12.0±2.3 92.1±2.5 
3 0 
0.25% 11.3±1.8 149.1±2.5 
0.5% 1215±1.5 465.6±6.9 
0.75% 10.8±1.0 814.3±32.6 
Tlm('(mm) 1.0% 10.5±0.4 1090.0:198.3 
Figure A17: Lux response of P. putida KT2440 biosensor to L64 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 12-9-2008, (B) Study 2 
performed on 12-19-2008, (C) Study 3 performed on 2-2-2009, (D) Study 4 performed on 2-20-
2009, (E) Study 5 performed on 12-11-2008. Means of analytical replicates and standard 
errors are shown for each study. All the three studies with Pluronic L64 were performed within 
3 months of its receiving from the supplier. 
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Table A9: Lux response (RLU values) of P. putida KT2440 biosensor to L64 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables L64 (A), (B), 
(C), (0) and (E), respectively 
L64 (A) 
- ~" 
0 0.1 0.25 o.s 0.75 1.0 
l 2 3 A,._ so 1 2 3 A,._ so 1 2 3 A,._ SD 1 2 , A ... SD l 2 3 A-s- SD 1 2 3 





10 123.4 1116. 83.4 107.E 171. 28.6 31.A 310 '.!Cl.4 1.7 22.4 23.1 26f 24.3 2.1 49.7 811 69.1 66.9 62 55.5 56.6 58.4 56.8 1.5 66.7 66.8 800 67.li 123 
20 76.3 682 10., 71.6 4.2 30.7 29.1 31.1 30.7 1.0 31.3 38.1 35.1 34.8 3.4 Rll_! 4r;_9 62.0 M1 A.!I 60.8 73.9 75., 70.0 8.0 87 721 708 70.1 27 
30 61.9 58.1 59.7 59.9 1.9 32.4 33.7 43.1 136.4 5.9 41.1 39.1 44.1 41.5 2.5 IA"9 687 87.1 660 1.9 77.1 87.0 81.6 81.9 5.0 81.1 """ 91.0 ·ea.a 6A 
40 59.2 57.3 49.6 55.4 5.1 34.0 31.8 30.3 32.0 1.9 41.4 39.0 42.6 41.0 1.8 69.7 57.E 60. 59.1 1.4 82.9 79.8 84.2 82.3 2.3 901 92.9 96.3 93.3 2.8 
50 46.5 44.0 42.3 44.3 2.1 29.0 30.8 27.0 28.9 1.9 39.1 39.6 42.5 40.4 1.8 50.0 n.~ 60.1 812 11.! 52.7 55.5 57.4 55.2 2.4 74.• 70.9 69.9 71.7 2.3 
60 44.4 43.9 44.3 44.2 03 77 A ">D 1 i">CA 1">7"> 1 .. 37.6 '.l6.4 39.1 37.7 14 AQft A7 "" An" '4n, 68 ... 87.7 189.6 684 I 1-, -.nc 877 7ft7 AQA ... 
L64 (B) 
- C.-..ntrallon" 
0 0.1 0.25 o.5 0.75 1.0 
1 z 3 Avs. SD l 2 3 A,._ so 1 2 3 A,._ so l 2 a A ... so 1 2 3 "•· SD l z 3 A ... SD 
1 119.8 r141.• 156.4 139., 18.' 87.4 71.3 85. 81.2 8.7 72.6 73.! 73. 732 0.8 n.1 73.! 74.E 73.5 1.4 76.! 81.8 81.9 80.1 3.1 81.0 84.l 83~ 83.0 1.8 
10 123.4 116. 83.4 107.E 21. 49A 52.0 62.0 61.1 1.6 63.6 661 65. 65.4 1.6 87.1 88.1 86.~ 87.4 1.3 88.0 87.4 89.1 88.2 0.8 An.9 IA.117 84.7 90.1 5.0 
20 76.3 68.2 70.:i 71.6 4.2 468 47.:i 4A~ 47.7 1.3 52.3 52.5 54.' 53.1 1.1 Afl~ 1!12.8 902 897 3.3 ~00.l 104.7 103.! 103.1 2.1 Qr; 95. 104.1 982 51 
'lO 61.9 58.1 59.7 59.9 1.9 43.8 465 485 45.8 1.7 40.2 48.3 48.9 45.8 4.9 849 87 au 87.0 1.9 1109.! 113.2 118.~ 113.7 4.4 128.2 1133.' 1?7.9 ~?!I.' ?Q 
40 592 57.3 49.6 55.4 5.1 48.6 49.1 48.0 48.6 0.5 512 52.8 51.0 51.6 1.0 64.5 70.1 69.1 68.1 3.1 1120., 125.4 122.E 122.7 2.5 139.l 142.7 148.4 1143.E 4.4 
50 46.5 44.0 42.3 44.3 2.1 49.5 48.8 50.4 49.6 0.8 55.7 54.2 51.9 53.9 1.9 55.0 54.1 5U 562 2.4 90.6 90.6 90.5 90.6 0.0 132..!! ~32.E 130.4 i13U 1.3 




0 0.1 0.25 0.5 0.75 1.8 
1 2 3 A,._ so I z 3 A,._ so 1 2 3 A,._ so I z 3 A,._ so 1 z 3 A,._ so 1 z 3 A,._ so 
, 119.8 141.< 156.4 139.; 18.' 10-4.6 1117.1 12U 1114.E 8.8 1125.C 134.! 133.~ 131_; 5.5 180' 180.' 161. 180.~ 0.5 1TT.' ""4. 732.1 211.' ""· =1.• i??n_ '"5.' ~-- 2.3 
10 123.4 116. 83.4 1107.E 21. 84.1 83.7 80.8 82.8 1.8 97.6 97.2 97.C 97.3 0.3 17V 112.; 1TT. 174.1 3.1 210.0 tn3_; 232.3 1221.E 11., rn,.1 '.Mll.S t.?13.~ 212. no.1 
20 76.3 68.2 70. 71.6 4.2 60.5 60.E SH 59.7 1.5 89.5 91.8 90. 90.5 12 148.1 18U 150.7 1153 .• 7.0 200.S 188. 187.7 119V 7.3 1213 .,,.,,_~ 1199.< ,,._._ 7.4 
30 61.9 58.1 59.7 59.9 1.9 53.0 55.3 55.9 54.7 1.5 83.5 862 88.4 86.0 2.5 137.7 170.( 17U 11BP 7n.l 188.2 178. 176.3 180.! 6.4 180.( 187.:1 1178.! 181.2 6.5 
40 59.2 57.3 49.6 55.4 5.1 492 48.0 47.6 48.3 0.8 76.2 73.6 80.0 76.6 3.3 159-5 1741 170.l 116U 7.8 1672 165.! 159.9 164., 3.8 166.! 161.1 151U 162.5 3.5 
50 60.1 il;;Q 81 50.1 55.1 7.1 46.4 47.2 45.1 45.9 12 72.7 75.0 75.3 74.3 1.4 172.• 171.I 167J 1170.1 2.6 168.B 162. 167.E 166. 3.5 150.1 149.E 1155.< 151.B 31 
,;o 55.5 54 3 49.0 52.!l 3.5 .... 1 A11 ~~n d07 1., .. 63.0 67 '.\ 1117 3 6".9 ::.c. 171, 11.:a •&n <.Mt 87 •=. 1r.n 14n" 14D I ll7 ,~a •a• 
.. _ 
•rr d 1-.n 
L64 (D) 
11,- Concmlradm'I" 
0 0.1 0.25 o.s 0.75 1.8 
1 2 3 AV&-so 1 z 3 ...... so 1 z 3 Avs. so 1 z 3 AllS- SD I z 3 A,._ so l z 3 ...... so
1 224.7 1227.( 2312 1227.E 3.3 186.4 197.7 119U 191.1 8.1 188.E 172.4 167., 176.1 11. 181.1 181' l'>n7.., 190.1 14.1 184.S 199.! 1239.C 20H 128.( 125H 12n., 276.C 1266.1 13. 
10 186.5 1200. 182.1 1189.! 9.4 129.3 139.:! 184.• 14U 118. 1168., 183.7 203.C 185.0 17_, 213.• ?tKI ' ?142 212.• 2.7 184.3 1221.3 226.< 210.7 123.0 bn!._, me.; 238.• in'>.E 15.1 
20 149.0 168.( 161. 159.< 9.6 122.4 139.3 1148.! 138.7 113.; 158.< 169.C 173.E 167.C 7.8 1422 188.• 165.1 165' 17<1. 206.3 t.?27.' 233. =.• 14.1 185.E 11eu 7n1.7 1193.( 8.1 
30 153.B 167. 14V 154.< 12A 133.5 146.C 1153.1 144.2 110.< 1152. 171.5 144., 156.2 13.! 147.e 17?• 182.7 187.E 118. 194.< 185.< ?115.1 195.1 9.6 1219.~ 184 179. 194. 21. 
40 130.2 140.! 144.( 138., 7.2 122.8 124.5 98.5 115.3 1141 157 1TT.3 1193.1 176.1 18.< 1n.• 155.< 17U 188.1 11.' 122.9 163.! 179.C 155.' ?0.1 190.1 178.1 214.1 194.1 1H 
50 145.B 143. 144.6 144.1 1.0 122.7 127. 1 126.• 1'"'" 2.4 158.1 184.2 172.! 17U 113.( 17U 134.• 194.E 188.E 31.1 170.1 191.1 180.2 180.! 10.! 178.1 190J 11BU 184.< 5.9 




0 0.1 O.ll 0.5 0.75 1.0 
1 z 3 AVS- SD 1 z 3 A.._ so 1 z 3 AVII- so 1 z 3 ""-· so 1 z 3 A.._ SD 1 z 3 A.._ so 
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Figure A18: % RLU relative to control for defined concentrations of Pluronics L64 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 















































































Figure A19: Lux response of P. putida KT2440 biosensor to P85 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 12-8-2008, (B) Study 2 
performed on 12-10-2008, (C) Study 3 performed on 12-20-2008, (D) Study 4 performed on 12-
18-2008. Means of analytical replicates and standard errors are shown for each study. All 
149 
the three studies with Pluronic P85 were performed within a month of its receiving from the 
supplier. 
Table A10: Lux response (RLU values) of P. putida KT2440 biosensor to P85 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables P85 (A), (B), 
(C) and (0), respectively 
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Figure A20: % RLU relative to control for defined concentrations of Pluronics P85 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 
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Figure A21: Lux response of P. putida KT2440 biosensor to F108 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
of treatment are shown. (A) Data from Study 1 performed on 6-30-2008, (B) Study 2 
performed on 1-28-2009, (C) Study 3 performed on 2-6-2009, (D) Study 4 performed on 2-12-
2009. Means of analytical replicates and standard errors are shown for each study. All the 
three studies with Pluronic F108 were performed within 2 months of its receiving from the 
supplier. 
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Table A11: Lux response (RLU values) of P. putida KT2440 biosensor to F108 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables F108 (A), (B), 
(C) and (D), respectively 
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Figure A22: % RLU relative to control for defined concentrations of Pluronics F108 at 
1 O min intervals. Means of analytical replicates and standard errors are shown for each 
study. 
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Figure A23: Lux response of P. putida KT2440 biosensor to L61 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
165 
of treatment are shown. (A) Data from Study 1 performed on 1-15-2009, (B) Study 2 
performed on 1-23-2009, (C) Study 3 performed on 12-17--2008, (D) Study 4 performed on 1-12-
2009. Means of analytical replicates crnd standard errors are shown for each study. All the 
three studies with Pluronic L61 were performed within 2 months of its receiving from the 
supplier. 
Table A12: Lux response (RLU values) of P. putida KT2440 biosensor to L61 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables L61 (A), (B), 
(C) and (D), respectively 
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Figure A24: % RLU relative to control for defined concentrations of Pluronics L61 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 
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Figure A25: Lux response of P. putida KT2440 biosensor to L31 Pluronic at defined 
doses (mg/L). Changes in Lux output relative to control and cell culturability after 60 min 
173 
of treatment are shown. (A) Data from Study 1 performed on 3-4-2009, (B) Study 2 performed 
on 1-15-2009, (C) Study 3 performed on 2-25-2009, (D) Study 4 performed on 12-16-2008, (E) 
Study 5 performed on 1-12-2009. Means of analytical replicates and standard errors are 
shown for each study. All the three studies with Pluronic L31 were performed within 3 months 
of its receiving from the supplier. 
Table A13: Lux response (RLU values) of P putida KT2440 biosensor to L31 Pluronic at 
defined doses (mg/L). RLU values from the replicate studies are shown in tables L31 (A), (B), 
(C), (D) and (E), respectively 
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Figure A26: % RLU relative to control for defined concentrations of Pluronics L31 at 10 
min intervals. Means of analytical replicates and standard errors are shown for each 
study. 
